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ABSTRACT OF DISSERTATION
POST-TRAUMATIC SLEEP FOLLOWING DIFFUSE TRAUMATIC BRAIN INJURY
By
Rachel Kathleen Rowe
Traumatic brain injury (TBI) is a major cause of death and disability throughout
the world with few pharmacological treatments available for individuals who suffer from
neurological morbidities associated with TBI. Cellular and molecular pathological
processes initiated at the time of injury develop into neurological impairments, with
chronic sleep disorders (insomnia, hypersomnolence) being among the somatic,
cognitive and emotional neurological impairments. Immediately post-injury, TBI patients
report excessive daytime sleepiness, however, discordant opinions suggest that
individuals should not be allowed to sleep or should be frequently awoken following brain
injury. To provide adequate medical care, it is imperative to understand the role of acute
post-traumatic sleep on the recovery of neurological function after TBI.
The aim of this thesis was to examine post-traumatic sleep after experimental
TBI, defined as an increase in sleep during the first hours post-injury. In these studies,
we non-invasively measured sleep activity following diffuse brain injury induced by
midline fluid percussion injury to examine the architecture of post-traumatic sleep in
mice. We detected significant injury-induced increases in acute sleep for six hours
regardless of injury severity or time of day injury occurred. We found concurrent
increases in cortical levels of the sleep promoting inflammatory cytokine interleukin 1beta. We extended the timeline of post-injury sleep recording and found increases in
post-traumatic sleep are distinctly acute with no changes in chronic sleep following
diffuse TBI. Further, we investigated if post-traumatic sleep was beneficial to
neurological outcome after brain-injury by disrupting post-traumatic sleep. Disruption of
post-traumatic sleep did not worsen functional outcome (neuromotor, sensorimotor,
cognition) at one week after diffuse TBI. With sufferers of TBI not always seeking
medical attention, our final studies investigated over-the-counter analgesics and their
effect on post-traumatic sleep and functional outcome. Acute administration of
analgesics with varying anti-inflammatory properties had little effect on post-traumatic
sleep and functional outcome.
Overall, these studies demonstrated translational potential and suggest sleep
after a concussion is part of the natural recovery from injury. While disrupting sleep does
not worsen outcome, it is in no way beneficial to recovery. Additionally, a single

analgesic dose for pain management following concussion plays little role in short term
outcome.
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Chapter One: Introduction
Traumatic Brain Injury
Traumatic brain injury (TBI) is a major cause of death and disability
throughout the world (Langlois et al. 2006; Reilly 2007; Roozenbeek et al. 2013).
In the United States between 2002 and 2006, the Centers for Disease Control
and Prevention estimated 52,000 deaths, 275,000 hospitalizations, and
1,365,000 emergency department visits resulting from TBI each year (Faul et al.
2010b). It is also estimated that as high as 42% of TBIs are not included in these
statistics because 1.2-4.3 million survivors of mild TBI annually do not seek
medical attention (Setnik and Bazarian 2007). TBI is a heterogeneous disorder
leading to varying degrees of symptoms based on mode and severity of injury.
Brain injury can lead to both short and long-term impairment, including cognitive
(Albensi and Janigro 2003), and behavioral (Yeates et al. 2002) deficits as well
as increasing the risk for developing neurodegenerative disease (Masel and
DeWitt 2010), post-traumatic headaches (Theeler et al. 2013), and/or psychiatric
disorders (Arciniegas et al. 2000). There is no approved pharmacological
treatment for TBI and current medical care focuses primarily on controlling
physiological parameters including intracranial pressure and blood pressure
(Wang et al. 2006). Severity of TBI is categorized based on the Glasgow Coma
Scale (GCS) which reliably classifies the severity of TBI based on clinical
symptoms with a total GCS score classifying their injury as mild (score: 13-15),
moderate (score: 9-12) or severe (score: <9) (Prins et al. 2013). The studies of
this thesis will focus on mild (non-severe) brain injury.
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There are two principal classifications for TBI delineated by injury
mechanisms. Focal brain damage is caused by contact injury resulting in
contusion

and

laceration

and

diffuse

brain

injury

is

caused

by

acceleration/deceleration injury resulting in diffuse axonal injury and swelling
(Werner and Engelhard 2007). TBI is characterized by two pathological phases:
cellular injury resulting from primary impact and the ensuing secondary injury
mediated by pathological processes (Werner and Engelhard 2007). Secondary
injury occurs over time post-injury with a gradual onset beginning minutes to
hours after impact and contributes to the clinical morbidities associated with TBI.
Little can be done to mitigate the mechanical disruption associated with the
primary insult and the biochemical cascades initiated shortly after the time of
injury can impair physiological function and ultimately worsen long-term outcome
(Gentleman 1999).
The complex neurovascular responses after TBI require investigations that
involve the immune, circulatory, and central nervous systems of live animals. The
long term consequences of TBI include a host of emotional, cognitive, and
sensory deficits that can degrade quality of life. Specific aspects of brain injury,
such as cell death, have been successfully modeled with in vitro neural injury
(Morrison et al. 1998; Geddes et al. 2003). However, in vitro models cannot be
sustained over chronic time points to evaluate injury progression and lack the
complex interactions among systems that characterize TBI neuropathy.
Additionally, current computer models cannot reproduce the complicated
pathophysiology of TBI. A wide range of well-accepted animal models are
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available for neurotrauma investigation and the use of whole animal models is
justified for TBI research and deemed appropriate for conduct of pre-clinical
studies (Chen et al. 2008). Therefore, neurotrauma research necessitates live
animal models of human TBI, which must be employed within the existing animal
welfare regulatory environment. To study TBI pre-clinically, a range of
experimental models of TBI are used in research differing in primary injury
mechanisms. To generate injuries with characteristics of mild to severe TBI, the
most commonly used animal models include fluid percussion (FP), controlled
cortical impact (CCI), and weight-drop injury (Prins et al. 2013). While the initial
impact in these models differ, all produce secondary injury mechanisms with
characteristic physiological responses common to human TBI (Prins et al. 2013).
The studies of this thesis utilize a fluid percussion animal model of diffuse brain
injury to answer specific scientific questions.
Among secondary injury mechanisms, TBI depletes adenosine-5’triphosphate (ATP) causing failure of energy dependent membrane ion pumps,
increases reactive oxygen species (ROS), increases intracellular concentrations
of free radicals caused by the activation of lipid peroxidases, and increases
inflammatory mediating cytokines (Fan et al. 1995; Werner and Engelhard 2007).
Fluid percussion injury decreases ATP levels in both the cortex and
hippocampus of rats starting as early as two hours post-injury with declines in
ATP levels remaining up to 24 hours post-injury (Lifshitz et al. 2003; Aoyama et
al. 2008). An impact acceleration model of TBI has also shown decreases in ATP
levels in rats immediately following brain injury (Signoretti et al. 2001). Similarly,
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secondary injury mechanisms after brain injury increase oxidative stress through
enhanced production of ROS, free radicals, and lipid peroxidation (Reimund
1994; Gopalakrishnan et al. 2004).
Neuroinflammatory cascades are also initiated as part of the secondary
injury following TBI (Pleines et al. 2001). The resident macrophages of the
central nervous system, microglia, respond immediately following brain injury and
release inflammatory mediators which include inflammatory cytokines and
chemokines (Davalos et al. 2005; Nimmerjahn et al. 2005; Bachstetter et al.
2013). Elevated cytokine signaling has been observed across experimental
models and human TBI, highlighting their involvement in pathological and
reparative processes triggered by injury (Morganti-Kossmann et al. 2001; Frugier
et al. 2010; Semple et al. 2010; Ziebell and Morganti-Kossmann 2010).
Sleep Disturbances Following TBI
Secondary injuries of TBI, consequences of ongoing cellular events, often
cause further damage and lead to physiological consequences (Werner and
Engelhard 2007; Prins et al. 2013). Pathological processes initiated at the time of
injury develop into neurological impairments, with sleep disturbances among the
somatic, cognitive and emotional neurological impairments (Castriotta et al.
2007; Kempf et al. 2010). Among other neurological consequences of TBI, sleep
disturbances are commonly reported in the acute phase of TBI, some of which
persist through more chronic periods (Castriotta et al. 2007; Verma et al. 2007;
Kempf et al. 2010). Published reports indicate an incidence as high as 70% of
TBI survivors suffer from sleep-wake disturbances (Cohen et al. 1992; Orff et al.
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2009). Similar sleep disorders develop across the spectrum of TBI, including
children and adolescents (Tham et al. 2012), ultimately impacting the quality of
life. Proper identification and treatment of sleep-wake disturbances following TBI
can facilitate outcomes in vigilance, working memory, and capacity of language
processing (Wiseman-Hakes et al. 2013).
Excessive

daytime

sleepiness

is

the

most

common

sleep-wake

disturbance reported among TBI patients (Castriotta et al. 2007; Kempf et al.
2010; Baumann 2012) and is characterized primarily by an increase in sleep
propensity. Post-traumatic hypersomnia, an increased need in sleep over a 24
hour period, is also reported among the most common sleep-wake disturbances
reported following TBI (Baumann 2012; Billiard and Podesta 2013). Other
commonly reported disorders include narcolepsy, delayed sleep phase,
insomnia, and fatigue (Ouellet and Morin 2006; Verma et al. 2007; Kempf et al.
2010; Baumann 2012). These sleep disturbances in TBI survivors make an
impact on rehabilitation of patients after injury and can exacerbate symptoms
such as pain and cognitive deficits (Mathias and Alvaro 2012; Bhalerao et al.
2013).
Functions of Sleep
Sleep is a state of immobility with reduced responsiveness, differing from
coma or anesthesia by the ability to rapidly be reversed. While sleep is an
evolutionarily conserved phenomenon that is essential for survival (Banks and
Dinges 2007), the function of sleep is not completely understood. In the absence
of sleep, however, there are significant detriments in cognitive function (Krueger
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et al. 1999). Early hypotheses suggest the function of sleep is restoration,
eliminating waste and restoring depleted energy sources (Oswald 1980), and
energy conservation (Walker and Berger 1980; Xie et al. 2013). More recent
hypotheses conclude sleep homeostasis reflects synaptic changes, highlighting a
cellular need for sleep and indicate plasticity and learning as the major functions
of sleep (Tononi and Cirelli 2003; Huber et al. 2004).
There are substantial variations in the amount of daily sleep required from
mammal to mammal, with some animals demanding 18 to 20 hours of sleep and
others needing a minimal 3 to 4 hours (Siegel 2005). Ecological studies suggest
a correlation between a species’ diet and sleep time and a link between body
mass, brain size, and duration of cumulative sleep cycle (Zepelin et al. 2005). A
possible explanation for this relationship is the inverse correlation of metabolic
rate with both body and brain mass (Siegel 2005). High metabolic rates, linked to
biochemical changes which modulate sleep, result in the generation of reactive
oxygen species (ROS) by mitochondria, and sleep time may be a defense
against this oxidative stress (Siegel 2005). The relationship between sleep and
defense against oxidative damage has been outlined in studies showing sleep
deprivation in the rat increases oxidative stress in the hippocampus, subcortical
regions, and peripheral tissue (Eiland et al. 2002; Ramanathan et al. 2002;
Everson et al. 2005; Siegel 2005).
Adenosine, a byproduct of energy metabolism is also a regulator of brain
energy (Brown et al. 2012). During sleep, adenosine may serve as a homeostatic
regulator of brain energy (Benington and Heller 1995; Scharf et al. 2008).

6

Wakefulness requires a higher metabolic rate than sleep, leading to increased
levels of extracellular adenosine as a result of ATP breakdown (Pull and
McIlwain 1972; Madsen and Vorstrup 1991; Maquet 1995).

Sleep reduces

neuronal activity which correlates to a surge in ATP (Dworak et al. 2010).
Together, these studies suggest sleep-induced increases in ATP allow for
increased anabolic processes during sleep, highlighting the restorative
biosynthetic function of sleep (Dworak et al. 2010; Brown et al. 2012).
There is an accumulation of evidence supporting sleep plays a role in
synaptic homeostasis, regulating the synaptic weight of the brain (for review, see
(Tononi and Cirelli 2003; Tononi and Cirelli 2006)). During wakefulness there is
synaptic potentiation in cortical circuits which accumulate as a net increase in
synaptic weight, and it is hypothesized this accumulation of synaptic potentiation
during wakefulness leads to increases in sleep (Tononi and Cirelli 2006). This is
supported by animal studies which conclude increasing wakefulness in rats by
gentle handling increases the expression of synaptic potentiation markers (Cirelli
and Tononi 2000).
Lastly, sleep has a role in the modulation of the immune system. Sleep is
coupled to immunological responses such as inflammation with observations
suggesting sleep patterns may predict clinical outcome of disease processes
(Toth 1995). Long periods of enhanced sleep in rabbits inoculated with E. coli, S.
aureus, or C. albicans lead to a more favorable prognosis and less severe clinical
signs when compared to a microbial challenge followed by short periods of
enhanced sleep then prolonged sleep suppression (Toth and Krueger 1988; Toth
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et al. 1993). Sleep promoting stimuli, such as cytokines interleukin-1 (IL-1) and
tumor necrosis factor (TNF), expressed transiently after microbial challenge,
likely contribute to the sleep enhancement observed during microbial infections
(Toth 1995). Furthermore, inflammatory mediating cytokines produced in vivo by
infection parallel the cytokines produced by secondary injury cascades following
TBI (Chensue et al. 1991; Clark et al. 1991; Wakabayashi et al. 1991; Bjork et al.
1992; Ziebell and Morganti-Kossmann 2010). These data suggest sleep may
naturally be promoted following brain injury.
Thesis Outline
While acute sleep disturbances are among one of the most commonly
reported clinical neurological impairments following TBI, there is a lack of
investigations into the duration, manipulation, and implications of this posttraumatic sleep. The overall goal of this thesis was to identify the role of posttraumatic sleep in recovery from diffuse brain injury. The overarching hypothesis
was that diffuse brain injury leads to increases in acute sleep, and that
manipulation of that sleep leads to worsened outcome.
To test the hypothesis that injury-induced sleep enhances recovery of
neurological function following diffuse brain injury, the studies described in this
dissertation used a novel non-invasive sleep monitoring cage system to gain
insight into acute sleep immediately following TBI in the mouse. The most
fascinating finding was that sleep is significantly increased following brain injury
independent of injury severity or time of day injury occurs. Also, injury-induced
increases in sleep extend into the first week post-injury but do not develop into
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chronic sleep disturbances using our midline fluid percussion injury model. These
data, in chapter two and three, are the first to provide insight into post-traumatic
sleep following diffuse brain injury.
Chapter Four further explores acute post-traumatic sleep by investigating
the relationship between immediate disruption of post-traumatic sleep and
functional outcome following diffuse brain injury in the mouse. In summary, these
studies were designed to disrupt the acute injury-induced increase in sleep
observed in Chapter Two, and to elucidate the potential relationship between
acute sleep and functional outcome following TBI. Taken together our results
from these studies indicate there is a recovery of neurological function despite
immediate sleep disruption following diffuse brain injury in the mouse.
Despite the large portion of mild TBI survivors not seeking medical
attention (Setnik and Bazarian 2007) who likely self-medicate for post-traumatic
headache, the role of over-the-counter (OTC) pain relief medicines in the course
of brain injury is not completely understood. Finally, Chapter Five focused on
acute OTC pharmacological intervention following TBI. We demonstrated that a
one-time dose administered at the time of injury did not adversely affect
behavioral outcome following diffuse TBI in the mouse. While there were druginduced alterations of sleep profiles within the first 24 hours post-injury, changes
in sleep did not result in changes in functional outcome. In addition, further
implications of drug intervention and TBI outcome are covered in the Appendix.
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Collectively, the data of these studies have a translational impact which
will help inform clinical recommendations for the at-home treated population of
mildly concussed TBI survivors. With TBI individuals not always seeking medical
attention, it is important that standardized messages about acute at-home care
are properly delivered following investigations into the nature of post-traumatic
sleep. If sleep is restorative and promotes plasticity, then post-traumatic sleep
may aid in recovery of function following injury, which could change the
standards of care for brain-injured patients. The studies of this thesis are
comprised of five manuscripts submitted (Chapter 3, Chapter 5) or accepted
(Chapter 2, Chapter 4, Appendix) for publication in peer-reviewed journals.

Copyright © Rachel Kathleen Rowe 2013
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Preface to Chapter Two

The aim of the experiments in Chapter Two was to investigate acute sleep
following diffuse brain injury. Using non-invasive sleep monitoring cages
significant increases in sleep were detected over the first six hours post-injury
which were independent of both injury severity and time of injury. Injury-induced
increases in cortical IL-1β were measured over the first nine hours post-injury. In
conclusion, it was demonstrated that secondary injury cascades may contribute
to the overall increase in acute sleep measured following experimental diffuse
brain injury in the mouse.

Chapter Two: Diffuse Brain Injury Induces Acute Post-Traumatic Sleep

Summary
Clinical observations report excessive sleepiness immediately following
TBI, however, there is a lack of experimental evidence to support or refute the
benefit of sleep following a brain injury. The aim of this study is to investigate
acute post-traumatic sleep. Sham, mild or moderate diffuse TBI was induced by
midline fluid percussion injury (mFPI) in male C57BL/6J mice at 9:00 or 21:00 to
evaluate injury-induced sleep behavior at sleep and wake onset, respectively.
Sleep profiles were measured post-injury using a non-invasive, piezoelectric
cage system. In separate cohorts of mice, inflammatory cytokines in the
neocortex were quantified by immunoassay, and microglial activation was
visualized by immunohistochemistry. Immediately after diffuse TBI, quantitative
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measures of sleep were characterized by a significant increase in sleep (>50%)
for the first 6 hours post-injury, resulting from increases in sleep bout length,
compared

to

sham.

Acute

post-traumatic

sleep

increased

significantly

independent of injury severity and time of injury (9:00 vs 21:00). The proinflammatory cytokine IL-1β increased in brain-injured mice compared to sham
over the first 9 hours post-injury. Iba-1 positive microglia were evident in braininjured cortex at 6 hours post-injury. Post-traumatic sleep occurs for up to 6
hours after diffuse brain injury in the mouse regardless of injury severity or timeof-day. The temporal profile of secondary injury cascades may be driving the
significant increase in post-traumatic sleep and contribute to the natural course of
recovery through cellular repair.
Introduction
TBI is a major cause of death and disability throughout the world with little
pharmacological treatment for the individuals who suffer from lifelong
neurological morbidities associated with TBI. Brain injury can lead to both short
and long-term impairment, including cognitive (Albensi and Janigro 2003), and
behavioral (Yeates et al. 2002) deficits as well as increasing the risk for
developing neurodegenerative disease (Masel and DeWitt 2010) and/or
psychiatric disorders (Arciniegas et al. 2000). Little can be done to mitigate the
mechanical disruption associated with the primary insult and the biochemical
cascades initiated shortly after the time of injury can impair physiological function
and ultimately worsen long-term outcome (Gentleman 1999).
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Clinical studies have provided evidence to support the hypothesis that
brain injury contributes to chronic sleep disturbances as well as leads to
excessive daytime sleepiness (Baumann et al. 2007; Castriotta et al. 2007;
Kempf et al. 2010; Baumann 2012). Far less is known about the acute
relationship between TBI and sleep. Immediately after TBI, secondary injury
mechanisms may impair physiological functions associated with the homeostatic
regulation of sleep. For example, secondary injury processes result in glia
activation and initiation of marked inflammatory responses. Injury-induced
inflammation is mediated by the production of cytokines, such as the proinflammatory, cytokine interleukin-1 beta (IL-1β), which can have dual roles as
sleep regulatory substances (SRSs) (Krueger and Majde 1995; Krueger et al.
2007). Elevated cytokine signaling has been observed across experimental
models and human TBI, highlighting their involvement in pathological and
reparative processes triggered by injury (Morganti-Kossmann et al. 2001; Frugier
et al. 2010; Semple et al. 2010; Ziebell and Morganti-Kossmann 2010). However,
cytokines which are SRSs can also modulate sleep-wake behavior, primarily
enhancing sleep by acting on sleep circuits of the brain (Krueger et al. 2001a;
Krueger et al. 2007).
Secondary injury mechanisms of TBI deplete ATP causing failure of
energy-dependent membrane ion pumps, increase reactive oxygen species
(ROS), increase intracellular concentrations of free radicals caused by activation
of lipid peroxidases, as well as increase inflammatory mediating cytokines (Fan
et al. 1995; Werner and Engelhard 2007). A low energy state, high ROS, and the
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increase of certain cytokines have all been implicated in increased sleep
propensity and sleep duration (Dworak et al. 2010; Chikahisa and Sei 2011).
Thus, secondary injury processes following TBI have the potential to induce posttraumatic sleep. The magnitude and duration of the induction of post-traumatic
sleep are unknown. Further, as these cellular processes continue, chronic sleep
issues may develop.
The biological function of sleep remains controversial, however, prevailing
hypotheses suggest the function of sleep is restorative, conservative, and
adaptive (Tononi and Cirelli 2006; Chokroverty 2010). In the absence of sleep,
humans exhibit deficits in attention, memory, learning, and higher cognitive
processes (McCoy and Strecker 2011). Sleep is regulated by homeostatic
processes as well as circadian processes (Borbely and Achermann 1999) such
that injury may disrupt the signaling required to maintain a healthy sleep profile. If
sleep is regenerative in function, then acute post-traumatic sleep may improve
outcome from brain injury. This study is the first of its kind to investigate acute
sleep following diffuse brain injury.
To characterize acute sleep patterns in brain-injured mice, a non-invasive
sleep monitoring cage system was used to continuously record post-traumatic
sleep. The sleep monitoring cage system allows reliable, immediate and
continuous sleep monitoring by using piezoelectric materials configured as
highly-sensitive pressure detectors incorporated into the bottom of the animal
cage to determine rest-activity based on motion and breathing patterns (Donohue
et al. 2008). Sleep is discriminated from wake every 2 seconds from tapered 8
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second overlapping windows based on classification algorithms that exploit the
limited mouse sleeping postures and distinct respiratory patterns consistent with
sleep, compared to rest and activity (Flores et al. 2007; Donohue et al. 2008).
This technology is also adapted to measure the polycyclic sleep pattern of mice,
accounting for short interruptions and brief arousals in sleep. The cage system
recognizes short bouts (a single sleep episode) lasting only seconds as well as
extended bouts lasting longer than a minute.
Sleep can complicate the understanding of injury processes following TBI
(Baumann 2012). The investigation of post-traumatic sleep may lead to rational
interventions to mitigate damage. The present study was designed to examine
injury-induced alterations in acute sleep following TBI. Clinical observations
indicate that patients report excessive sleepiness immediately following TBI
(Castriotta et al. 2007). In view of these observations, we hypothesized that
diffuse brain injury would induce acute post-traumatic sleep in the mouse. The
lack of biomedical research surrounding the controversial question whether one
should sleep or be frequently awoken immediately following brain injury adds to
the importance of investigating post-traumatic sleep, specifically in the acute
period. In neurosurgical wards TBI patients are frequently awoken during the first
day after injury to check for possible worsening of their consciousness, a
condition that requires immediate action. In more mild conditions, the practice of
keeping a brain-injured individual awake is controversial. Here we demonstrate
significant increases in acute sleep post-injury regardless of injury severity or
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time of day. Post-traumatic sleep occurs during the same time as increased
cortical expression of SRS cytokines and inflammation.
Methods
Animals
Male C57BL/6J mice (Harlan Laboratories, Inc., Indianapolis, IN) were
used for all experiments (n=75). The animals were housed in a 14 h light/10h
dark cycle at a constant temperature (23°C ± 2° C) with food and water available
ad libitum according to the Association for Assessment and Accreditation of
Laboratory Animal Care International. Animals were acclimated to their
environment following shipment for at least three days prior to any experiments.
After surgery, animals were evaluated daily for post-operative care by a physical
examination and documentation of each animal’s condition. All studies were
approved by the University of Kentucky Institutional Animal Care and Use
Committee (IACUC Protocol Number: 2007-0142). All surgery was performed
under isoflurane anesthesia, and efforts were made to minimize suffering.
Midline Fluid Percussion Injury (mFPI)
Mice (20-24g) were subjected to midline fluid percussion injury (mFPI)
consistent with methods previously described (Lifshitz 2008). Mice were
anesthetized using 5% isoflurane in 100% oxygen for five minutes and the head
of the animal was placed in a stereotaxic frame with continuously delivered
isoflurane at 2.5% via nosecone. While anesthetized, the animal’s body
temperature was maintained using a Deltaphase® isothermal heating pad
(Braintree Scientific Inc., Braintree, MA). A midline incision was made exposing
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bregma and lambda, and fascia was removed from the surface of the skull. A
trephine (3 mm outer diameter) was used for the craniotomy, centered on the
sagittal suture between bregma and lambda without disruption of the dura. An
injury cap prepared from the female portion of a Luer-Loc needle hub was fixed
over the craniotomy using cyanoacrylate gel and methyl-methacrylate (Hygenic
Corp., Akron, OH). The injury cap was closed using a Luer-Loc cap and mice
were placed in a heated recovery cage and monitored until ambulatory before
being returned to their sleep cage.
For injury induction 24 hours post-surgery, animals were re-anesthetized
with 5% isoflurane delivered for five minutes. The cap was removed from the
injury-hub assembly and the dura was visually inspected through the hub to
confirm it was intact with no debris. The hub was then filled with normal saline
and attached to a tube connected to the male end of the fluid percussion device
(Custom Design and Fabrication, Virginia Commonwealth University, Richmond,
VA). An injury of moderate severity (1.4 atm) was administered by releasing the
pendulum onto the fluid-filled cylinder. Sham-injured animals underwent the
same procedure except the pendulum was not released. Animals were monitored
for the presence of a forearm fencing response and righting reflex times were
recorded for the injured animals as indicators of injury severity (Hosseini and
Lifshitz 2009). The righting reflex time is the total time from the initial impact until
the animal spontaneously rights itself from a supine position. The fencing
response is a tonic posturing characterized by extension and flexion of opposite
limbs that has been validated as an overt indicator of injury force magnitude
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(Hosseini and Lifshitz 2009). The injury hub was removed and the brain was
inspected for uniform herniation and integrity of the dura. The dura was intact in
all animals, none were excluded as technical failures. The incision was cleaned
using saline and closed with sutures. Moderate brain-injured animals had righting
reflex recovery times greater than six minutes and a positive fencing response.
Sham injured animals recovered from anesthesia within 20 seconds. After
spontaneously righting, animals were placed in a heated recovery cage and
monitored until ambulatory (approximately 5 to 15 minutes) before being returned
to their sleep cage. Adequate measures were taken to minimize pain or
discomfort. Following all surgical procedures the investigators were blinded to
experimental groups to prevent bias in latter animal studies.
Sleep Recordings
The non-invasive sleep cage system (Signal Solutions, Lexington, KY)
used in this study consisted of 16 separate units that could simultaneously
monitor the sleep and wake states over several days. The cage system classified
sleep and wake behavior based on methods previously described (Flores et al.
2007; Donohue et al. 2008). Each cage unit housed the mice individually with
separate 18x18 centimeter walled compartments and attached food and water
structures (Donohue et al. 2008). The cages had open bottoms that allowed them
to be placed on a base with a Polyvinylidine Difluoride (PVDF) sensor on the
cage floor (Donohue et al. 2008). The PVDF sensors were coupled to an input
differential amplifier and pressure signals were generated and classified by the
non-invasive high-throughput classifier as motions consistent with either wake
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activity or the inactivity associated with sleep (Donohue et al. 2008). Sleep was
characterized primarily by periodic pressure measurements with regular
amplitudes, typical of respiration from a still mouse. In contrast, movements
characteristic of wake were both the absence of the characteristic sleep signal
and higher amplitude, irregular spiking associated with volitional movements
(Figure 2.3). The piezoelectric signals were classified by the automated sleep
scoring system in two second epochs as “sleep” or “wake”. The tapered
segmentation window was advanced every two seconds and features associated
with the characteristics just described were computed. A linear discriminant
classifier based on these features was applied to assign a binary label given to
each point associated with the center of the window (see dashed line in Figure
2.3) (Donohue et al. 2008). Data collected from the cage system were binned
over specified time periods (e.g. 5 minutes, 1 hour) using a rolling average of the
percent sleep, as well as binned by length of individual bouts of sleep and the
median bout lengths were calculated.
Mice were acclimated to the cages and sensors were tested for 8 days
prior to injury (Figure 2.1A). The animals were removed from their home cages
for the midline craniotomy surgery and were placed back into their specific cage
following the surgery. The following day the mice were removed from their home
cage and were subjected to mFPI or sham injury. As soon as the mice were
ambulatory (approximately 5 to 15 minutes), they were returned to their original
sleep cage and the sleep recordings started to measure sleep continuously for 7
days (Donohue et al. 2008). Previous validation of the sleep cages in agreement
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with human observation resulted in classification rates of 90% or higher
(Donohue et al. 2008). This sleep cage system was a valid method for monitoring
acute sleep in injured animals without confounding the injury. Placement of
invasive EEG equipment for recordings can compromise the dura and adds
external weight to the head of the rodent possibly exacerbating the brain-injury.
A two-way analysis of variance (ANOVA) including repeated measures
was used to compare the mean percent sleep of brain-injured mice to uninjured
shams over time followed by a Bonferroni post-hoc test. Statistical significance
was assigned when p < 0.05.
Tissue preparation and cytokine measurement
At selected time points (1, 3, 9, 12, 24, 48, 168 hours) post-injury or sham
operation, mice were given an overdose of sodium pentobarbital and
transcardially perfused with phosphate buffered saline (PBS) (Figure 2.1A). Mice
were decapitated and the brains were dissected on ice and snap frozen in liquid
nitrogen then stored at -80° C until used. The protein levels of a panel of
inflammatory cytokines were measured in the neocortex by Meso Scale
Discovery (MSD) multiplex immunoassay (sector imager 2400, Meso Scale
Discovery; Gaithersburg Maryland) (Figure 2.1B) as previously described
(Bachstetter et al. 2011). Brain cortex was homogenized using high shear
homogenizer (Omni TH115), in a 1:10 (w/v) of ice-cold lysis buffer consisting of
PBS containing 1μg/ml Leupeptin, 1mM PMSF, and 1mM EDTA. The cortical
homogenate was centrifuged at 14,000xg for 20 minutes at 4°C in a
microcentrifuge. Fifty microliters of the resulting supernatant was loaded per well
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of the custom MSD plate, and IL-1β levels were determined by MSD assay
(Mouse Proinflammatory 7-Plex Ultra-Sensitive (K15012C)). IL-1β levels in the
cortex were normalized to the total amount of protein in the sample loaded as
determined by BCA Protein Assay (Pierce).
Cytokine levels of IL-1β were compared between uninjured sham and
brain-injured mice. Increases in cytokine levels in the brain-injured mice were
analyzed over a time course using a one-way ANOVA and selected comparisons
were made using the Bonferroni post hoc test.
Tissue preparation for immunohistochemistry
At 6 hours post-injury or sham operation, mice were given an overdose of
sodium pentobarbital and transcardially perfused with 4% paraformaldehyde after
a (PBS) flush. Brains were removed and placed in 4% paraformaldehyde
overnight. Brains were immersed in serial dilutions (10%, 20%, and 30%) of
sucrose for 24 hours each. The brains were removed from the 30% sucrose and
frozen at -20° C. After freezing, brains were sectioned in the coronal plane at 20
µm, mounted onto glass slides, and stored at -80° C.
IBA-1 immunohistochemistry
Slides were removed from -80° C, placed in an oven at 60° C for
approximately 4 hours and then rinsed three times for 5 minutes each in PBS.
Next, the slides were incubated in 4% goat serum blocking solution for 1 hour.
The slides were incubated with the primary antibody (rabbit anti-ionized calcium
binding adaptor molecule 1 (IBA-1), 1:1000, Wako Chemicals 0199-19741) and

21

stored at room temperature overnight. Slides were rinsed three times in PBS and
the

secondary

antibody

(biotinylated

horse

anti-rabbit,

1:250,

Vector

Laboratories) was added then slides were incubated on a rocker at room
temperature for 1 hour. The slides were washed in PBS three times for 5 minutes
each and tertiary stain was applied (streptavidin Alexa© Fluor 594, 1:1000,
Jackson Laboratories) and slides were incubated for 1 hour at room temperature.
Lastly, slides were rinsed three times in PBS and coverslipped with FluoromountG anti-fade medium (Southern Biotech). The cortex was examined for microglia
activation in response to brain-injury using a Zeiss Axio Scope with attached
digital camera.
Results
Diffuse TBI induces acute post-traumatic sleep in the mouse
Immediately after diffuse TBI, mean percent sleep was significantly
increased in brain-injured animals compared to sham for the first 6 hours postinjury (F(1, 45)=6.545, p=0.00007) (Figure 2.2A). After 6 hours post-injury, the
mean percent sleep of the injured mice (n=31) normalized and was
indistinguishable from sleep in the sham (n=16) through 7 days post-injury (data
not shown). A more detailed analysis was performed by calculating the mean
percent sleep over five minute intervals for the first hour post-injury to examine
the increase in sleep observed acutely post-injury. The mean percent sleep
showed a significant time-dependent increase in sleep over the first hour postinjury (F(11,495)=8.22, p<0.0001) (Figure 2.2B) until maximum sleep was
reached. In addition, analysis over the first hour-post injury showed a significant
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group effect (F(1,45)=37.00, p<0.0001) (Figure 2.2B) indicating TBI induced a
significant increase in mean percent sleep compared to the uninjured sham.
Increase in acute post-traumatic sleep in the diffuse brain-injured mouse was
associated with increased median bout lengths of sleep (Figure 2.2C). We
observed a significant increase in the median bout length of brain-injured mice
compared to sham for the first 4 hours post-injury (F(1,45)=2.9138, p=0.032).
This increase in bout length indicated that the increase in mean percent sleep
observed acutely post-injury (Figure 2.2A) could result from mice sleeping for
longer durations during each bout, as opposed to sleeping more bouts after
diffuse TBI.
Post-traumatic sleep bouts are interrupted by volitional movement and
arousal similar to uninjured shams
Immediately after diffuse TBI, mean percent sleep was significantly
increased in brain-injured mice compared to uninjured sham. To analyze the
signals used to classify sleep, the raw piezoelectric sensor data was extracted
and compared between brain-injured and sham mice within the first hour postinjury. Uninjured sham mice showed a periodic rhythm associated with the
motion of breathing, approximately 3 Hz, with regular amplitude typical of sleep in
the mouse (Figure 2.3A). These sleep bouts were interrupted by higher
frequency and amplitude signals that correspond to movements consistent with
wake activity (Figure 2.3A). The sleep-wake classifier plotted with the decision
threshold (Figure 3, below raw signal) were classified as sleep activity above the
threshold and as wake activity below the threshold. In brain-injured mice, sleep
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activity showed similar rhythmic breathing classified as sleep (Figure 2.3B). As in
the uninjured sham, sleep was interrupted by high amplitude and frequency
signals corresponding to volitional movement. Interruptions of sleep bouts by
volitional movement indicate the brain-injured animals terminate sleep bouts in a
similar manner to uninjured mice, suggesting that brain-injured mice are
responsive, capable of movement, and not in a comatose state of
unresponsiveness. As shown, sleep bouts in brain-injured mice are longer in
duration than in uninjured mice (Figure 2.3B).
Increase in acute post-traumatic sleep in the diffuse brain-injured mouse
was independent of injury time of day
Sham or brain injury was administered at transitional time points (9:00 or
21:00) in the light/dark cycle (Figure 2.1A). We observed an increase in the mean
percent sleep of brain-injured mice compared to sham when mice were injured at
9:00, following the onset of the light cycle (Figure 2.4A). Brain-injury resulted in a
significant increase in mean percent sleep for the first 3 hours following injury as
compared to the mean percent sleep of sham (F(1,25)=15.95, p=0.0005).
Similarly, we observed an increase in post-traumatic sleep when mice were
subjected to injury at 21:00, following the onset of the dark cycle (Figure 2.4B).
We recorded a significant increase in mean percent sleep for the first 3 hours
following brain-injury compared to uninjured shams (F(1,17)=4.42, p=0.0506).
Regardless of injury time of day, post-traumatic sleep was increased to
comparable levels (45-65%) and became indistinguishable from sleep in the
sham after 3 hours post-injury. In contrast, diurnal pressures associated with the
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change in the light/dark cycle were evident on the mean percent sleep of
uninjured sham animals, as expected. The mean percent sleep of uninjured
sham mice in the 9:00 group was significantly higher than the mean percent
sleep of sham mice in the 21:00 group (F(1,15)=6.303, p=0.0240). This finding is
representative of the nocturnal activity of mice.
Increase in acute post-traumatic sleep in the diffuse brain-injured mouse
was independent of injury severity
Two levels of experimental injury severity were used to test the effects of
injury severity on post-traumatic sleep. We define injury severity as mild (0.8 atm)
and moderate (1.2-1.3 atm) according to the righting-reflex and the fencing
response (see methods). Post-traumatic sleep was not significantly different
between mild and moderate brain-injured mice (Figure 2.5). A significant
increase in post-traumatic sleep was observed acutely following both mild and
moderate injury compared to the uninjured sham (F(2,44)=3.4773, p=0.00037).
No significant difference was found between mild brain-injured mice and
moderate brain-injured mice, indicating the significant increase in post-traumatic
sleep is independent of injury severity.
Secondary injury responses temporally associate with the increase in
acute post-traumatic sleep in the diffuse brain-injured mouse
Following brain injury there is an up-regulation of pro-inflammatory
cytokines (Helmy et al. 2011) that include IL-1β (Fan et al. 1995; Frugier et al.
2010). IL-1β is a cytokine with sleep regulatory substance activity (Krueger and
Majde 1995; Fang et al. 1998; Krueger et al. 2001a) which could partially explain
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post-traumatic sleep. A temporal profile of IL-1β indicated that cortical levels
increased rapidly following moderate injury as compared to uninjured sham
(Figure 2.6A). Levels of IL-1β peak at or near 9 hours post-injury and return to
baseline levels by 12 hours post-injury. There was a significant increase in IL-1β
levels in brain-injured animals compared to sham (F(7,21)=6.474, p=0.0004) and
selected comparisons using the Bonferroni post-hoc analysis indicated a
significant increase between sham and brain-injured mice at 1, 3 and 9 hours
post-injury.
Microglia morphology, an indicator of microglia activation, was examined
after diffuse brain injury in the mouse using Iba-1 immunohistochemistry. Iba-1
labels all microglia, however, distinct morphological differences in Iba-1 stained
microglia were observed in brain-injured (mild and moderate injury, 09:00, Figure
2.6 C,D) compared to uninjured (Figure 2.6B) cortex at 6 hours post-injury.
Microglia in brain-injured cortex showed morphologies consistent with activated
microglia, including amoeboid cell bodies with thick, densely labeled processes
(denoted by arrowheads). In contrast, thin, highly ramified processes of ramified
microglia (denoted by arrows) were present in the uninjured sham cortex.
Discussion
Brain injury survivors report varying degrees of sleep disturbances (Orff et
al. 2009), however, the contribution of acute post-traumatic sleep to the injury
itself remains unclear. To achieve this long-term goal, we undertook the present
study to measure the acute sleep response to diffuse TBI, which we term posttraumatic sleep. We chose to focus on acute sleep post-injury, because sleep
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itself may be restorative and aid in the recovery of function following injury. By
non-invasively recording sleep immediately following diffuse brain injury, we were
able to document the induction of post-traumatic sleep. Altogether, our data, for
the first time, support the hypothesis that diffuse brain injury promotes acute
post-traumatic sleep in the mouse, and secondary injury related cellular
processes coincide with this increase.
Current sleep research associated with TBI has focused on chronic sleep
disorders in the sequelae of human injury (Verma et al. 2007; Orff et al. 2009;
Boone et al. 2012). The lack of studies investigating acute sleep following TBI
heightens the importance of studies in this field, because evidence promoting or
disrupting sleep after TBI may change the standard of care for brain-injury
patients. By investigating the role of post-traumatic sleep, interventions can be
developed to mitigate damage. This study used a non-invasive sleep monitoring
cage system which reliably measures injury-induced alterations in sleep
(Donohue et al. 2008) immediately following injury. Without the surgical
procedures required for EEG recordings, we avoided the contraindications of an
electrode in the brain at the time of injury which would create contusion or
cavitation and most importantly allowed for post-injury sleep to be measured
within minutes of the initial injury. The piezoelectric sensor cages, in conjunction
with computer algorithms, recorded the sleep of each individual mouse (injury
and sham) and created a detailed sleep profile that included mean percent sleep
and median bout length. The cage system allows for sleep profiles of braininjured and sham mice to be measured in exactly the same way. We found that
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post-traumatic sleep was significantly increased after brain injury, regardless of
time of day or injury severity, with longer median sleep bouts underlying the
overall increased post-traumatic sleep.
Despite the limitation of not being able to discriminate stages of sleep
(rapid-eye-movement-sleep, slow wave sleep), the piezoelectric cage system is
capable of accurately distinguishing wake from sleep (Flores et al. 2007). While
the sleep cage system has been well validated in distinguishing sleep from wake
with comparisons between EEG/EMG and human observation in normal mice
(Donohue et al. 2008), it is possible that sleep could be over-estimated in TBI
mice. If this were true, we would expect percent sleep times to be greatest in the
first hour after injury and for moderate TBI to show a greater sleep increase than
mild TBI. Since TBI mice were able to make postural adjustments and voluntary
movements that signal wake, post-traumatic sleep is likely to be sleep, rather
than a more severe condition. While the post-traumatic sleep bears many
hallmarks of normal sleep, we cannot rule out that the increased sleep time is in
part due to non-convulsive seizures with behavioral and temporal dynamics
similar to sleep. We discount non-convulsive status epilepticus (NCSE) as a
component of post-traumatic sleep because the development of epilepsy
following experimental brain injury does not occur within the first week post-injury
(D'Ambrosio et al. 2004). Following severe lateral fluid percussion in rats, EEG
recordings indicated no injury-induced seizure within the first six hours post-injury
(Kharatishvili et al. 2006).

Furthermore, EEG/EMG signal features used to

determine sleep stages in normal mice may be compromised after brain injury
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and affect sleep-wake scoring. It should also be noted EEG/EMG recordings can
result in false positive or negative sleep determination leading to possible error
when used as the sole arbiter of sleep. For the purposes of this study, sleep
determination did not rely fundamentally on EEG/EMG measures, but more
simply is associated with a reversible perceptual disengagement from the
environment, marked by a suspension of voluntary bodily functions. Ongoing
work with the sleep cage system suggests that signal processing can distinguish
REM from NREM sleep based on more irregular breathing during REM stages.
Future work will determine whether the increases we observed in post-traumatic
sleep arise from increases in REM or NREM sleep, or most likely from increases
in both.
In order to explore the impact of diffuse TBI on natural sleep, mice were
subjected to injury at two time points in their circadian rhythms. By conducting
the injuries at the light/dark transition, we investigated whether post-traumatic
sleep was a result of the brain injury or an interaction with natural biological
tendencies to sleep. The 9:00 time point followed the onset of the light cycle, a
time when nocturnal mice were expected to sleep. The 21:00 time point followed
the onset of the dark cycle, a time when nocturnal mice are most active. Sleep
patterns of uninjured mice showed circadian related pressures. Acute posttraumatic sleep significantly increased in comparison to the sleep of uninjured
shams independent of the time of day mice were subjected to injury. This degree
of increase in sleep following TBI is similar to the mean percent sleep of mice
following 6 hours of sleep deprivation (Huber et al. 2000). It is possible that the
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circadian clock itself or its outputs are dysregulated by TBI (Boone et al. 2012),
which would contribute to injury-induced sleep being independent of the time at
which the injury occurs. However, immediate permanent pathology is unlikely, as
sleep parameters return to sham levels beyond 6 hours post-injury.
We also examined the relationship between injury severity and posttraumatic sleep. Severity of the initial injury is considered a major determining
factor for magnitude of secondary injury processes and outcome following TBI
(Curry et al. 2011), which led to the hypothesis that injury severity would directly
impact post-traumatic sleep. Contrary to our hypothesis, both mildly and
moderately brain-injured mice showed similar significant increases in posttraumatic sleep compared to sham values. Even mild injury significantly
increased sleep, which urges continued investigation into the contribution of posttraumatic sleep to the natural course of the injury. The possibility exists to induce
an even milder injury, which may have less impact on post-traumatic sleep;
however this may reduce/eliminate all other cellular hallmarks of TBI as well.
Unfortunately, because mildly and moderately injured mice have comparable
increases in acute post-traumatic sleep, the utility of sleep to serve as a
diagnostic biomarker for injury severity is limited.
Our data also exclude the possibility of an injury-induced coma, as an
extreme manifestation of sleep. Severe TBI can lead to coma, however, our
brain-injured mice exhibit a brief period of non-responsiveness measured by the
suppression of the righting reflex. Also, the maximum median bout length,
measured in seconds, was 30 seconds, followed by periods of wake activity,
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which excludes the possibility of an injury-induced coma since mice voluntarily
woke between sleep bouts. These periods of wake activity during the interbout
interval between sleep activity were clearly shown by the piezoelectric sensor
data.
TBI is characterized by two pathological phases: cellular injury resulting
from primary impact and the ensuing secondary injury mediated by pathological
processes (Werner and Engelhard 2007). Secondary injury occurs over time
post-injury with a more gradual onset beginning minutes to hours after impact
and contributes to the clinical morbidities associated with TBI. Post-traumatic
sleep in 5 minute intervals showed that the increase in mean percent sleep over
the first hour post-injury is time dependent (Figure 2.2B). If the primary impact
solely contributed to post-traumatic sleep, then an immediate increase in posttraumatic sleep to a maximum level would have been observed. The secondary
injury cascades that play a role in inducing sleep following diffuse TBI likely
include post-traumatic signaling that activate glia, as evidenced by increased
production of pro-inflammatory cytokines, such as IL-1β, in both animal models
and human head injury patients (Fan et al. 1995; Helmy et al. 2011).
Activated microglia can contribute to the production of IL-1β after TBI.
Once produced, IL-1β acts locally to affect neuronal assemblies, altering their
functional status, as well as acting on sleep regulatory circuits (Krueger et al.
2007). Our group has accumulated evidence for circuit disruption, dismantling
and reorganization in the diffuse-injured cortex, particularly the whisker sensory
circuit of the rat (Lifshitz et al. 2007; Hall and Lifshitz 2010; McNamara et al.
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2010; Cao et al. 2012; Lifshitz and Lisembee 2012). Microglia likely act as the
effectors of circuit disruption (Cao et al. 2012) by producing cytokines and as a
consequence influence the functional state of those circuits. The impact of
microglia can then extend beyond local circuits to sleep regulatory circuits and
ultimately induce sleep (Krueger and Majde 1995; Krueger et al. 2001a; Krueger
2008). In the injured mouse brain, these microglial signaling processes that
influence sleep last 6 hours post-injury and remain to be determined in the
human condition.
Our data show that IL-1β was upregulated in the cortex following diffuse
TBI, and previous studies have reported that humans undergoing IL-1β therapy
report excessive sleepiness (Krueger et al. 2007). Injections of IL-1β enhance
NREM sleep (Krueger et al. 2001a) and application of IL-1β to the
somatosensory cortex leads to enhanced EEG delta wave activity (Yasuda et al.
2005). These data indicate a mechanistic link between IL-1β and sleep. In the
injured cortex, IL-1β continues to increase, peaking at or near 9 hours post-injury
and returning to sham levels by 12 hours post-injury (Figure 2.6A), similar to the
increase in mean percent sleep in brain-injured mice. Collectively, these data
suggest that post-traumatic sleep may involve inflammatory mediated processes
and the upregulation of pro-inflammatory cytokines that can act as sleep
regulatory substances. Our immunohistological staining indicated activation of
microglia in the cortex of mild and moderate brain-injured mice compared to
uninjured sham at 6 hours post-injury, coinciding with elevated cytokine levels in
moderate injury and the end of post-traumatic sleep. Activated microglia produce
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pro-inflammatory cytokines, including those with dual roles as SRSs (IL-1β, IL-6,
TNFα) (Wisor et al. 2011), as indicated by pharmacological inhibition of microglia
reducing levels of pro-inflammatory cytokines. The infiltration and activation of
microglia may be a potential source of sleep regulatory factors in the injured
brain (Alder et al. 2011; Cao et al. 2012; Jin et al. 2012), regardless of injury
severity. We argue that increases in sleep following TBI may result from the
inflammatory response associated with the secondary injury in which elevated
cytokine levels are associated with activation of microglia after brain injury.
Future studies are needed to examine the mechanistic relationship between
changes in cytokine levels and sleep.
Conclusion
The current study demonstrated that acute sleep was increased following
diffuse TBI, and injury-induced cellular cascades may contribute to this increase.
The increase in sleep was independent of time of day that the injury occurred
and the injury severity. Increases in median bout length contributed to the overall
increase in sleep observed post-injury. Further studies need to determine the
cellular benefit or detriment of acute post-traumatic sleep on recovery following
TBI (and other neurological conditions) by disrupting acute sleep. Understanding
the role of acute post-traumatic sleep on outcome can begin to answer the
controversial question, “Should one sleep, be frequently awoken or left
uninterrupted after a concussion?”
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Chapter Two: Figures

Figure 2.1 Schematic of the study design.
Two cohorts of mice were used based on experimental outcome measures: (A)
sleep recordings and (B) cortical samples and histology. (A) Mice were
acclimated to piezoelectric sleep cages for 8 days while sample sleep recordings
were monitored to test signal integrity. All mice received a midline craniotomy
one day prior to brain or sham injury. Mice were divided into 2 groups based on
the time of day they were subjected to injury (9:00, 21:00). Within each group,
mice were selected at random and subjected to sham, mild (0.8 atm) or
moderate (1.2-1.3 atm) diffuse brain injury by midline fluid percussion (mFPI)
(n=47). Following injury, mice were placed back into piezoelectric sleep cages
and post-traumatic sleep was recorded for 7 days. (B) For biochemistry and
histology, mice received a midline craniotomy one day prior to injury or sham
injury. Mice were subjected to sham, or moderate (1.2-1.3 atm) diffuse brain
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injury (9:00) and cortical samples were retrieved at 1, 3, 9, 12, 24, 48, 168 hrs
(n=25). Tissue was also collected and prepared for histology 6 hrs post-injury
(n=3).
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Figure 2.2 Diffuse TBI in the mouse disrupts acute post- traumatic sleep
parameters compared to uninjured sham.
(A) A multivariate ANOVA showed a significant increase in mean percent sleep
over the first 6 hours post-injury compared to the uninjured sham (mean ±SEM;
sham n=16; injured n=31; F(1, 45)=6.545, p=0.00007). After 6 hours post-injury,
the mean percent sleep of injured mice normalized to sham mean percent sleep
levels and remained comparable for 7 days post-injury (data not shown). (B) A
detailed analysis of the acute post-traumatic sleep (in the first hour) following
diffuse TBI indicated a significant time dependent effect on the increase in sleep.
A multivariate ANOVA of the rolling average of the mean percent sleep over 5
min intervals showed post-traumatic sleep significantly increased over the first
hour post-injury with a significant effect of time (mean ±SEM; sham n=16; injured
n=31; F(11,495)=8.22, p<0.0001) and group (mean ±SEM; sham n=16; injured
n=31; F(1,45)=37.00, p<0.0001). Bonferroni post hoc analysis was used (*, p <
0.05). (C) Acutely post-injury, the brain-injured mice showed an increase in
median bout length compared to shams. A multivariate ANOVA revealed an
increase in bout length significant over the first 4 hours post-injury (mean ±SEM;
sham n=16; injured n=31; F(1,45)=2.9138, p=0.032). This increase in bout length
suggested that the increase in mean percent sleep observed acutely post-injury
could result from mice sleeping for longer durations, as opposed to sleeping
more bouts after diffuse TBI.
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Figure 2.3 Representative sleep-wake recordings in the first hour postinjury showed sleep bouts interrupted by brief arousal and movement.
Uninjured sham mice showed a periodic rhythm of breathing motion (~3 Hz) with
regular amplitude typical of sleep, interrupted by high frequency and amplitude
signals corresponding to movement consistent with an awake mouse (A). Diffuse
brain-injured mice showed similar rhythmic breathing classified as sleep
interrupted by frequency and amplitude variations corresponding to movement
during interbout intervals of sleep (B). The red lines represent the raw
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piezoelectric sensor data over a one minute (top) or 25 second (bottom) interval.
The discontinuous blue line indicates the decision classifier over two second
intervals to classify sleep activity from wake activity. The broken green line
delineates the threshold (in arbitrary units) to determine sleep activity (above the
threshold) from wake activity (below the threshold).
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Figure 2.4 Significant increase in post-traumatic sleep is independent of
the time of day of the injury.

41

Mice subjected to mild or moderate injury at 9:00 (A), following the dark/light
transition showed significant increases in acute post-traumatic sleep compared to
uninjured sham. A multivariate ANOVA and Bonferroni post-hoc analysis was
used (mean ±SEM; sham n=12; injured n=17; F(1,25)=15.95); *, p < 0.05). Mice
subjected to mild or moderate injury at 21:00 (B), following the light/dark
transition also showed significant increases in acute post-traumatic sleep
compared to sham. A multivariate ANOVA and Bonferroni post-hoc analysis was
used (mean ±SEM; sham n=5; injured n=14; F(1,17)=4.42; *, p < 0.05). An
increase in sleep is observed acutely following TBI and is observed over the
course of the first 3 hours in injured mice compared to sham. After 3 hours, sleep
began to normalize in the injured animals and became indistinguishable from
sleep in the sham. Mean percent sleep of uninjured sham mice in the 9:00 group
was significantly higher than the mean percent sleep of sham mice in the 21:00
group (F(1,15)=6.303, p=0.0240), as expected.
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Figure 2.5 The significant increase in post-traumatic sleep is observed
acutely following both mild and moderate injury.
A multivariate ANOVA showed a significant increase in mean percent sleep
between injured mice and uninjured shams over the first 6 hours post-injury with
no significant difference between mildly injured mice compared to moderately
injured mice (mean ±SEM; sham n=16; mild n=16; moderate n=15;
F(2,44)=3.4773, p=0.00037).
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Figure 2.6 Inflammation following diffuse TBI in the mouse.

(A) Temporal profile of IL-1β. The temporal profile indicated that levels in the
cortex increase rapidly following moderate injury (9:00) as compared to uninjured
sham. Levels of IL-1β peak at or near 9 hours post-injury and return to baseline
levels by 12 hours post-injury (One-way ANOVA, mean ±SEM; sham n=7; injured
n=22; F(7,21)=6.474; p=0.0004). Selected comparisons were made (Bonferroni
post-hoc), asterisk denotes significance (*, p < 0.05) compared to sham. (B, C,
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D) Microglia morphology, an indicator of microglia activation, was examined after
mFPI in the mouse using Iba-1 immunohistochemistry. Iba-1 labels all microglia,
however, tissue from a 6 hr sham (40x) (B) compared to a 6 hr mild injury (40x)
(C) and a 6 hr moderate injury (40x) (D) show distinct differences in microglia
morphology. Microglia in sham (B) demonstrated thin ramified processes
(denoted by arrows) strongly contrasting the larger cell bodies and thicker
processes (denoted by arrowheads) characteristic of activated microglia
observed in the diffuse injured mouse (C, D).
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Preface to Chapter Three

The aim of the experiments in Chapter Three was to test if our current
model of diffuse brain injury produced chronic sleep disturbances similar to those
reported by TBI patients. Using non-invasive sleep cages, sleep was measured
following diffuse brain injury and injury-induced increases were detected in sleep
during the first week post-injury. Furthermore, it was shown that these increases
did not extend beyond week one, and were not present in weeks two through
five.
Chapter Three: Diffuse brain injury does not affect chronic sleep patterns
in the mouse
Summary
The objective of this study was to test if our current model of diffuse brain
injury produces chronic sleep disturbances similar to those reported by TBI
patients. Adult male C57BL/6 mice were subjected to moderate midline fluid
percussion injury (n=7; 1.4 atm; 6-10 min righting reflex time) or sham injury
(n=5). Sleep-wake activity was measured post-injury using a non-invasive,
piezoelectric cage system. Chronic sleep patterns were analyzed weekly for
increases or decreases in percent sleep (hypersomnia or insomnia) and changes
in bout length (fragmentation). During the first week after diffuse TBI, braininjured mice exhibited increased mean percent sleep and mean bout length
compared to sham-injured mice. Further analysis indicated the increase in mean
percent sleep occurred during the dark cycle. Injury-induced changes in sleep,
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however, did not extend beyond the first week post-injury and were not present in
weeks 2-5 post-injury. Previously, we showed that the midline fluid percussion
model used in this study immediately increased post-traumatic sleep. The current
study extended the timeline of investigation to show that sleep disturbances
extended into the first week post-injury, but did not develop into chronic sleep
disturbances. However, the clinical prevalence of TBI-related sleep-wake
disturbances warrants further experimental investigation.
Introduction
Sleep disturbances are commonly reported neurological impairments in
the acute phase of TBI, some of which persist through more chronic periods
(Castriotta et al. 2007; Verma et al. 2007; Kempf et al. 2010). Pathological
processes initiated at the time of injury develop into neurological impairments,
with chronic sleep disturbances among the somatic, cognitive and emotional
neurological impairments (Castriotta et al. 2007; Kempf et al. 2010). According to
the literature, an incidence as high as 70% of TBI survivors suffer from sleepwake disturbances (Cohen et al. 1992; Orff et al. 2009). Similar sleep disorders
develop across the spectrum of TBI, including children and adolescents (Tham et
al. 2012). The high prevalence of sleep disorders and impact on quality of life
reported in both the adult and pediatric population of TBI survivors warrants
investigation of this injury-induced neurological impairment.
Excessive daytime sleepiness is a common sleep-wake disturbance
reported among TBI patients (Castriotta et al. 2007; Verma et al. 2007; Baumann
2012) and is characterized primarily by an increase in sleep propensity. Post-
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traumatic hypersomnia, an increased need to sleep over a 24 hour period, is
reported equally frequent following TBI (Baumann 2012; Billiard and Podesta
2013). These disturbances of increased sleepiness and fatigue can remain
several years after injury, becoming chronic impairments (Beaulieu-Bonneau and
Morin 2012; Tham et al. 2012; Billiard and Podesta 2013) and overall lowering
the quality of life of TBI patients. Injury-induced sleep disturbances also
potentially affect the course of recovery (Rao and Rollings 2002; Tham et al.
2012) and hinder rehabilitation (Mathias and Alvaro 2012). Chronic sleep
disturbances not only compromise recovery, but can intensify comorbidities
including anxiety, depression, cognitive deficits, and pain (Dean et al. 2012;
Mathias and Alvaro 2012; Bhalerao et al. 2013; Khoury et al. 2013). For these
reasons, exploring animal models that recapitulate aspects of injury-induced
sleep problems is timely.
With compromised sleep affecting patient outcome and quality of life,
understanding the role of sleep in recovery from brain injury is an important
health concern. Focusing on pre-clinical experimentation can potentially
accelerate the understanding of the relationship between brain injury and sleep.
Experimental models of TBI can be used to evaluate secondary injury
mechanisms underlying the pathophysiology of the injury and may be a useful
model to investigate chronic post-traumatic sleep. Our lab has recently shown
diffuse brain injury in mice increases sleep during the first six hours post-injury
(Rowe et al. 2013c). Here we investigate whether the same experimental model
shows chronic sleep disturbances associated with TBI. In this study we examine
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the relationship between TBI and chronic sleep using non-invasive piezoelectric
sleep cages to measure sleep for five weeks after midline fluid percussion injury
(mFPI) (Dixon et al. 1987). We hypothesize our model of diffuse brain injury will
produce chronic sleep deficits relevant to those reported by TBI patients, thereby
permitting further exploration of the role of sleep in recovery from brain injury.
Methods
Animals
Male C57BL/6 mice (Harlan Laboratories, Inc., Indianapolis, IN) were used
for all experiments (n=12). The animals were housed in a 12h light/12h dark
cycle at a constant temperature (23°C ± 2°C) with food and water available ad
libitum according to the Association for Assessment and Accreditation of
Laboratory Animal Care International. Animals were acclimated to their
environment following shipment for at least three days prior to any experiments.
After surgery, daily post-operative care was provided, including physical
examination and documentation of each animal’s condition. Animal use was
approved by the Institutional Animal Care and Use Committee at St. Joseph’s
Hospital and Medical Centre (Phoenix, AZ). All animals used in this study were
singly housed in the non-invasive sleep-monitoring cage system (Signal
Solutions, Lexington, KY).
Midline Fluid Percussion Injury (mFPI)
Mice (20-24g) were subjected to mFPI consistent with methods previously
described (Lifshitz 2008). Mice were anesthetized using 5% isoflurane in 100%
oxygen for five minutes and the head of the animal was placed in a stereotaxic
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frame with continuously delivered isoflurane at 2.5% via nosecone. While
anesthetized, the animal’s body temperature was

maintained using a

Deltaphase® isothermal heating pad (Braintree Scientific Inc., Braintree, MA). A
midline incision was made exposing bregma and lambda, and fascia was
removed from the surface of the skull. A trephine (3 mm outer diameter) was
used for the craniotomy, centred on the sagittal suture between bregma and
lambda without disruption of the dura. An injury cap prepared from the female
portion of a Luer-Loc needle hub was fixed over the craniotomy using
cyanoacrylate gel and methyl-methacrylate (Hygenic Corp., Akron, OH). The
injury cap was closed using a Luer-Loc cap and mice were placed in a heated
recovery cage and monitored until ambulatory before being returned to their
sleep cage. For injury induction 24 hours post-surgery, animals were reanesthetized with 5% isoflurane delivered for five minutes. The cap was removed
from the injury-hub assembly and the dura was visually inspected through the
hub to confirm it was intact with no debris. The hub was then filled with normal
saline and attached to a tube connected to the male end of the fluid percussion
device (Custom Design and Fabrication, Virginia Commonwealth University,
Richmond, VA). An injury of moderate severity (1.4 atm) was administered by
releasing the pendulum onto the fluid-filled cylinder. Sham-injured animals
underwent the same procedure except the pendulum was not released. Animals
were monitored for the presence of a forearm fencing response and righting
reflex times were recorded for the injured animals as indicators of injury severity
(Hosseini and Lifshitz 2009). The righting reflex time is the total time from the

50

initial impact until the animal spontaneously rights itself from a supine position.
The fencing response is a tonic posturing characterized by extension and flexion
of opposite limbs that has been validated as an overt indicator of injury force
magnitude (Hosseini and Lifshitz 2009). The injury hub was removed and the
brain was inspected for uniform herniation and integrity of the dura. The dura was
intact in all animals, none were excluded as technical failures. The incision was
cleaned using saline and closed with sutures. Moderate brain-injured animals
had righting reflex recovery times greater than six minutes and a positive fencing
response. Sham injured animals recovered from anesthesia within 20 seconds.
After spontaneously righting, animals were placed in a heated recovery cage and
monitored until ambulatory (approximately 5 to 15 minutes) before being returned
to their sleep cage. Adequate measures were taken to minimize pain or
discomfort.
Sleep Recordings
The non-invasive sleep cage system (Signal Solutions, Lexington, KY)
used in this study consisted of 16 separate units which simultaneously monitor
sleep and wake states, as previously published (Rowe et al. 2013c). Each cage
unit housed a single mouse inside 18 x 18 centimetre walled compartments with
attached food and water structures (Donohue et al. 2008). The cages had open
bottoms resting on Polyvinylidine Difluoride (PVDF) sensors serving as the cage
floor (Donohue et al. 2008). The non-invasive high-throughput PVDF sensors
were coupled to an input differential amplifier and pressure signals were
generated and classified by the classifier as motions consistent with either wake
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activity or the inactivity and regular breathing movements associated with sleep
(Donohue et al. 2008). Briefly, sleep was characterized primarily by periodic (3
Hz) and regular amplitude signals recorded from the PVDF sensors, typical of
respiration from a sleeping mouse. In contrast, signals characteristic of wake
were both the absence of characteristic sleep signals and higher amplitude,
irregular spiking associated with volitional movements. The piezoelectric signals
in two second epochs were classified by a linear discriminant classifier algorithm
based on frequency and amplitude to assign a binary label of “sleep” or “wake”
(Donohue et al. 2008). Mice sleep in a polycyclic manner (more than 40 sleep
episodes per hour) (McShane et al. 2010) and so mouse sleep was quantified as
the minutes spent sleeping per hour, presented as a percentage for each hour.
Data collected from the cage system were binned over specified time periods
(e.g. 1 hour) using the average of percent sleep, as well as binned by length of
individual bouts of sleep and the median bout lengths were calculated.
Sleep data were collected continuously for five weeks and organized into
week long intervals for analysis. Daily percent sleep was calculated by averaging
the percent sleep at each of 24 hours for all days of a given week post-injury.
Statistical Analysis
Data are shown as mean ± SEM and analyzed using statistical software
(GraphPad-Prism 6). Differences in mean percent sleep and mean bout length
were determined with a repeated measures two-way analysis of variance
(ANOVA) followed by Sidak’s multiple comparison test. Statistical significance
was assigned when p<0.05.
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Results
Diffuse TBI impacted percent sleep and mean bout length during the first
week post-injury.
We have previously reported significant increases in mean percent sleep
in brain-injured mice compared to uninjured shams over the first six hours postinjury (Rowe et al. 2013c). In the present study, we repeated this observation and
brain-injured mice slept significantly more over the first six hours compared to
uninjured shams (F(1,10)=7.209, p=0.0229; sham n=5, injury n=7; data not
shown). Overall, brain-injured mice slept significantly more than sham during the
first week post-injury (F(1,10)=17.61, p=0.0018; sham n=5, injury n=7; Figure
3.1A). To investigate “excessive daytime sleepiness”, we evaluated sleep
propensity during the dark phase. Mice are nocturnal, sleeping more during the
day with prolonged wakefulness at night, and therefore the mouse equivalent of
“excessive daytime sleepiness” in humans would most likely occur at night. Mean
percent sleep was evaluated over the dark cycle (the time the lights went off at
night until they turned on again the following morning). Our data indicate a
significant increase in mean percent sleep in brain-injured mice compared to
uninjured shams (F(1, 10)=11.29, p=0.0072; sham n=5, injury n=7; Figure 3.1B)
during the dark cycle. Brain-injured mice had the typical initial bout of high
wakefulness at dark onset (low percentage sleep), but did not sustain this
wakefulness to same degree as uninjured mice (Fig. 3.1A, 3.1B). By 01:00 in the
dark cycle, brain-injured mice were sleeping significantly more than uninjured
sham. Further, mean bout length was significantly increased in brain-injured mice
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compared to uninjured shams during the first week post-injury (F(1, 10)=5.186,
p=0.0460; sham n=5, injury n=7;Figure 3.1C), suggesting that the increase in
mean percent sleep observed was due to mice sleeping for longer durations
each bout, as opposed to sleeping more bouts, during the first week post-injury
(Figure 3.1A, 3.1C).
Diffuse TBI did not induce sleep disturbances between weeks two and five
post-injury.
Sleep recordings were extended beyond week one for the same mice to
investigate chronic sleep patterns post-injury. Identical percent sleep, dark cycle
sleep and mean bout length analyses were also conducted for weeks 2-5 postinjury. No significant injury-dependent effect on daily percent sleep was detected
in brain-injured mice (n=7) compared to sham mice (n=5) during post-injury week
two (F(1,10)=2.206, p=0.1683; Figure 3.2A), week three (F(1,10)=0.4557,
p=0.5150; Figure 3.2B), week four F(1,10)=0.7659, p=0.4020; Figure 3.2C), or
week five (F(1, 10) = 0.1282, p=0.7277; Figure 3.2D).
Further analysis of mean percent sleep focused on sleep only during the
dark cycle, placing emphasis on the nocturnality of mice. No injury-dependent
effect during the dark cycle on percent sleep was detected in brain-injured mice
compared to sham mice during post-injury week two (F(1,10)=0.07426,
p=0.7908; Figure 3.3A), week three (F(1,10)=0.2760, p=0.6108; Figure 3.3B),
week four F(1,10)=0.01892, p=0.8933; Figure 3.3C), or week five (F (1, 10) =
0.4322, p=0.8395; Figure 3.3D).
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No significant injury-dependent effect on daily mean bout length was
detected in brain-injured mice compared to sham mice during post-injury week
two (F(1,10)=0.3694, p=0.5569; Figure 3.4A), week four (F(1,10)=0.8686,
p=0.3733; Figure 3.4C), or week five (F(1,10)=0.2344, p=0.6387; Figure 3.4D).
During week three, brain-injured mice slept significantly longer average bouts
than shams F(1,10)=8.437, p=0.0157; Figure 3.4B), without specific post-hoc
differences at particular hours. Overall, brain-injury did not result in consistent
chronic changes in mean percent sleep or mean bout lengths of sleep.
Discussion
Sleep research associated with TBI has focused on sleep disturbances in
human injury (Verma et al. 2007; Orff et al. 2009; Baumann 2012). These chronic
disturbances are present in both pediatric and adult cases of TBI extending up to
three years after injury (Kaufman et al. 2001; Kempf et al. 2010). Commonly
reported sleep-wake disturbances after TBI include excessive daytime
sleepiness, fatigue, hypersomnia, and insomnia (Ouellet and Morin 2006; Verma
et al. 2007; Kempf et al. 2010; Baumann 2012). The high prevalence and
subjective nature of clinically reported chronic sleep disturbances warrant the
investigation of chronic sleep following experimental TBI. Our previous studies
showed a significant increase in percent sleep of brain-injured mice compared to
uninjured shams over the first six hours following diffuse TBI (Rowe et al. 2013c),
termed post-traumatic sleep. Injury-induced changes in sleep patterns were
limited to the first week after diffuse brain injury in the mouse, not extending into
chronic time points. Only in the first week post-injury did the total percentage
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sleep, sleep during the dark cycle and sleep bout length increase in brain-injured
compared to uninjured sham mice.
Excessive

daytime

sleepiness

and

post-traumatic

hypersomnia,

characterized primarily by an increase in sleep propensity, have been reported to
be among the most common sleep-wake disturbances following TBI (Baumann
2012). Hypersomnia, an increased need for sleep over a 24 hour period, differs
from excessive daytime sleepiness in which the increased need for sleep is
exclusively in the daytime (Baumann 2012). In the current study, mean percent
sleep was evaluated to determine if experimental brain injury resulted in
hypersomnia. After diffuse brain injury, an increase in overall mean percent of
sleep, hypersomnia, was observed only in the first week post-injury in braininjured mice compared to uninjured shams. This increase did not extend in to the
chronic period 2-5 weeks post-injury. To investigate excessive daytime
sleepiness, sleep propensity was analyzed during the dark phase, as mice
typically have prolonged wakefulness at night. Brain-injured mice slept
significantly more during the dark phase compared to uninjured shams only
within the first week post-injury. Taken together, injury-induced increases in sleep
are restricted to the first week post-injury. The first week becomes a critical
window for future investigations of brain-injury induced sleep. Sleep may
contribute to the natural recovery process following injury, which may be most
salient in the first week post-injury. Further investigation of the increase in sleep
observed over the first week may continue to inform clinical decisions and
improve treatment of TBI survivors.
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In the current study, mean bout length was analyzed as an indicator of
sleep fragmentation. Sleep fragmentation, an increase in awakenings during
sleep, leads to excessive daytime sleepiness and can cause changes in daytime
function similar to those found following sleep deprivation (Stepanski et al. 1984;
Stepanski 2002). Interruptions in sleep may prevent the benefit of the period of
sleep prior to the arousal (Bonnet 1985; Bonnet 1986; Stepanski 2002). Short
sleep bout lengths are indicative of arousals during the sleep cycle and could
potentially confound the reparative processes following brain injury. In this study,
sleep bout lengths in diffuse brain-injured mice were significantly longer than
sham mice during the first week post-injury, but not beyond. Hence, brain-injured
mice had longer periods of uninterrupted sleep compared to uninjured shams;
whether this is beneficial to outcome remains unknown. After controlled cortical
impact in mice, electroencephalography (EEG) recordings showed in the first
three days post-injury, brain-injured mice exhibit reduced ability to maintain
prolonged wakefulness (Willie et al. 2012). Together, these data indicate
experimental TBI increases sleep bout length and decreases prolonged
wakefulness, which could contribute to recovery from brain injury. It is possible
sleep bout length is only increased during the first week post-injury, because the
bulk of cellular recovery occurs during this period; an increase in sleep beyond
this time point may not be necessary.
The exact pathophysiology of post-traumatic sleep-wake disturbances
remains elusive. Excessive daytime sleepiness has been correlated to the injury
itself, concomitant with other pathophysiology associated with TBI, including
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damage to the hippocampus (Baumann et al. 2007; Baumann 2012). A
prospective patient study showed as many as 43% of patients have sleep wake
disturbances directly related to the injury itself (Baumann et al. 2007). The
secondary injury processes which affect sleep following diffuse TBI likely include
processes such as ATP depletion, an increased reactive oxygen species (ROS),
higher intracellular concentrations of free radicals, and elevated inflammation
mediating cytokines (Fan et al. 1995; Werner and Engelhard 2007). Impaired
signalling of sleep-wake modulating systems such as the hypocretin (orexin)
neuropeptide system, may also contribute to both acute and chronic sleepiness
following TBI (Baumann et al. 2005; Baumann et al. 2007; Willie et al. 2012).
Future studies can focus on the relationship between these signalling process
and sleep in the first week post-injury.
The reparative function of sleep is associated with increased brain ATP
levels (Dworak et al. 2010; Chikahisa and Sei 2011). Blocking ATP depletes
energy and increases sleep (Kalinchuk et al. 2003), suggesting that increases in
sleep following TBI may result from depletions in ATP. Decreases in ATP alter
cellular function contributing to cell death, as demonstrated in experimental TBI
(Headrick et al. 1994; Signoretti et al. 2001; Lifshitz et al. 2003; Aoyama et al.
2008). Fluid percussion injury decreases ATP levels in both the cortex and
hippocampus of rats starting as early as two hour post-injury with declines
remaining up to 24 hours post-injury (Lifshitz et al. 2003; Aoyama et al. 2008).
Similarly, an impact acceleration model of TBI decreases ATP levels in rats two
hours following a moderate injury and as early as ten minutes following a severe
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injury (Signoretti et al. 2001). If decrease in ATP is an immediate response to
brain injury, post-traumatic sleep may increase brain ATP levels. Similar
secondary injury mechanisms after brain injury increase oxidative stress through
enhanced production of ROS, reactive radicals, and lipid peroxidation (Ansari et
al. 2008), which could increase sleep. Sleep subsequently could remove
accumulated free radicals (Reimund 1994; Gopalakrishnan et al. 2004).
In diffuse brain injury, cortical levels of interleukin 1-beta (IL-1β)
immediately increased and then normalized by 12 hours post-injury through 1
week (Rowe et al. 2013c). In controlled cortical impact in the rat, interleukins (IL4, IL-5, IL-13) and tumour necrosis factor alpha (TNF-α) levels increased acutely
and recovered to baseline levels by three days post-injury (Dalgard et al. 2012).
A temporal profile of inflammatory cytokines following human TBI confirms the
translational relevance of these findings with peak levels of IL-1β, IL-6 and TNF
occurring within the first three days post-injury(Helmy et al. 2011). The proinflammatory cytokines, such as IL-1β, IL-6, and TNF, have dual roles as sleep
regulatory substances (Krueger and Majde 1995; Krueger et al. 2001b; Krueger
et al. 2007), which may contribute to the acute increase in sleep post-injury.
A limitation of the present study is the inability to distinguish between REM
(rapid eye movement) and nonREM sleep. While overall percent sleep and bout
length were not impacted at chronic time points, injury-induced alterations in
sleep architecture could occur, but not be measured by the non-invasive
monitoring system used in this study. Clinical studies show brain injury
contributes to changes in both types of sleep (Prigatano et al. 1982; Frieboes et
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al. 1999). Increases in REM sleep in the second sleep cycle have been reported
close to a year after TBI (Frieboes et al. 1999), while data suggest TBI patients
have less stage one nonREM sleep (Prigatano et al. 1982). Further analysis of
REM and nonREM sleep may reveal more subtle injury-induced chronic sleep
disturbances.
Our literature search showed numerous clinical reports of chronic sleepwake disturbances associated with TBI (Ouellet and Morin 2006; Verma et al.
2007; Kempf et al. 2010; Baumann 2012), however, experimental studies to date
have been terminated too early to evaluate chronic sleep disturbances (Helmy et
al. 2011; Willie et al. 2012; Rowe et al. 2013c) . To more completely understand
chronic sleep disorders in TBI survivors, future studies could investigate
secondary injury processes at chronic time points, focusing on processes that
may confound sleep physiology (e.g. ATP, free radicals, cytokines). A secondary
insult, such as a second brain injury, may be necessary to induce chronic sleep
disturbance in the mouse. Moreover, the present study disregarded the
contraindications of psychiatric sequelae, such as depression and anxiety, which
contribute to the development, if not maintenance, of sleep-wake disturbances in
TBI patients (Baumann 2012).
Conclusion
In conclusion, sleep was increased following diffuse TBI during the first
week post-injury. These injury-dependent changes in sleep were not maintained
thereafter. Further studies are needed to understand the contribution of sleep on
recovery following TBI, as well as other neurological conditions.
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affect chronic sleep patterns in the mouse.
This is a copy of an article in review in [Brain Injury] © [2013] [copyright Informa
Healthcare]; [Brain Injury] is available online at: http://informahealthcare.com
Copyright © Rachel Kathleen Rowe 2013
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Figure 3.1 Diffuse TBI impacted percent sleep and mean bout length in the
first week post-injury
(A) Overall, brain-injured mice slept significantly more than shams during the first
week post-injury (mean ±SEM; F(1,10)=17.61, p=0.0018; sham n=5, injury n=7).
Percent sleep was calculated by averaging the percent sleep at each of 24 hours
for all days of a given week post-injury, and this average is represented in the
graph. Differences between brain-injured mice and uninjured shams as indicated
(Sidak’s multiple comparison test, *, p<0.05). (B) Percent sleep in brain-injured
mice increased significantly compared to uninjured shams (two-way ANOVA,
mean ±SEM; F(1, 10)=11.29, p=0.0072; sham n=5, injury n=7) during the dark
cycle, with significant differences at 01:00 and 06:00 (Sidak’s multiple
comparison test; *, p<0.05). (C) Overall, the average bout length of sleep was
significantly longer in brain-injured mice compared to uninjured shams during the
first week post-injury (mean ±SEM; F(1, 10)=5.186, p=0.0460; sham n=5, injury
n=7), with significantly longer sleep bouts in the middle of the dark cycle for
brain-injured compared to uninjured mice (Sidak’s multiple comparison test; *,
p<0.05).
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Figure 3.2 Diffuse TBI did not chronically impact percent sleep.
Daily percent sleep was calculated by averaging the percent sleep at each hour
for all days of week two (A), three (B), four (C), and five (D) post-injury. No
significant differences in daily percent sleep were found between brain-injured
and sham mice during week two (F(1,10)=2.206, p=0.1683), week three
(F(1,10)=0.4557, p=0.5150), week four (F(1,10)=0.7659, p=0.4020), or week five
(F (1, 10) = 0.1282, p=0.7277).
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Figure 3.3 Diffuse TBI did not chronically impact percent sleep during the
dark cycle.
The mean percent sleep was evaluated during the dark cycle by calculating the
average percent sleep at each hour of the dark cycle for all days of week two (A),
three (B), four (C), and five (D). No injury-dependent effect during the dark cycle
on percent sleep was detected in brain-injured mice compared to sham mice
during

post-injury

week

two

(F(1,10)=0.07426,

p=0.7908),

week

three

(F(1,10)=0.2760, p=0.6108), week four F(1,10)=0.01892, p=0.8933), or week five
(F (1, 10) = 0.4322, p=0.8395).
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Figure 3.4 Diffuse TBI did not chronically impact mean bout length.
Daily mean bout length was calculated by averaging the mean bout length at
each hour for all days of week two (A), week three (B), week four (C), and week
five (D). No significant differences in average bout length slept were found
between brain-injured and sham mice during week two (F(1,10)=0.3694,
p=0.5569), week four (F(1,10)=0.8686, p=0.3733), or week five (F(1,10)=0.2344,
p=0.6387). Overall during week three, brain-injured mice slept significantly longer
average bouts than shams (F(1,10)=8.437, p=0.0157).
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Preface to Chapter Four
In the previous chapters, it has been demonstrated that diffuse brain injury
resulted in increased post-traumatic sleep over the first six hours following injury.
The aim of the experiments in Chapter Four was to examine the relationship
between immediate disruption of post-traumatic sleep and functional outcome in
the diffuse brain injured mouse. Using a gentle handling method of sleep
disruption, we showed short duration disruption of post-traumatic sleep did not
affect functional outcome, measured by motor and cognitive performance.
Chapter Four: Recovery of neurological function despite immediate sleep
disruption following diffuse brain injury in the mouse: clinical relevance to
medically untreated concussion
Summary
In this study we investigate the relationship between immediate disruption
of post-traumatic sleep and functional outcome in the diffuse brain-injured
mouse. Adult male C57BL/6 mice were subjected to moderate midline fluid
percussion injury (n=65; 1.4 atm; 6-10 min righting reflex time) or sham injury
(n=44). Cohorts received either intentional sleep disruption (minimally stressful
gentle handling) or no sleep disruption for six hours following injury. Following
disruption, serum corticosterone levels (ELISA) and post-traumatic sleep (noninvasive piezoelectric sleep cages) were measured. For 1-7 days post-injury,
sensorimotor outcome was assessed by Rotarod and a modified Neurological
Severity Score (NSS). Cognitive function was measured using Novel Object
Recognition (NOR) and Morris water maze (MWM) in the first week post-injury.
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Disrupting post-traumatic sleep for six hours did not affect serum corticosterone
levels or functional outcome. In the hour following the first dark-onset, sleep
disrupted mice exhibited a significant increase in sleep, however, this increase
was not sustained; there was no rebound of lost sleep. Regardless of sleep
disruption, mice showed a time-dependent improvement in Rotarod performance,
with brain-injured mice having significantly shorter latencies on day 7 compared
to sham. Further, brain-injured mice, regardless of sleep disruption, had
significantly higher NSS scores post-injury compared to sham. Cognitive
behavioral testing showed no group differences among any treatment group
measured by MWM and NOR. Short duration disruption of post-traumatic sleep
did not affect functional outcome, measured by motor and cognitive performance.
These data may refute post-traumatic sleep as a mechanism of recovery from
diffuse brain injury and impact TBI survivors not seeking medical attention.
Introduction
TBI is a major cause of death and disability throughout the world with few
pharmacological treatments available for individuals suffering from lifelong
neurological morbidities associated with TBI. Vascular, cellular and molecular
pathological processes initiated at the time of injury can compound the injury and
manifest into functional impairments. In the United States alone, the Centers for
Disease Control and Prevention estimated that between 2002 and 2006 there
were on average 52,000 deaths, 275,000 hospitalizations, and 1,365,000
emergency department visits related to TBI each year (Faul M 2010). Beyond
this, it is estimated that as high as 42% of TBIs are not included in these
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statistics, because approximately 1.2-4.2 million survivors of mild TBI do not seek
medical attention (Setnik and Bazarian 2007). A common neurological
consequence of mild TBI is excessive sleepiness immediately following injury
(Castriotta et al. 2007). However, discordant opinions suggest that individuals
should not be allowed to sleep or should be frequently awoken following mild
brain injury. The intentional sleep disruption employed outside of medical care
(e.g. at home) contrasts the unintentional sleep disruption associated with
diagnostic procedures in a clinical setting. This controversy is not supported by
peer-reviewed biomedical literature and the impact of sleep disruption
immediately following TBI upon functional recovery is not understood.
For the first time, this study investigates the contribution of acute posttraumatic sleep on the recovery of neurological function after diffuse TBI. Posttraumatic sleep may be beneficial to recovery from injury, because prevailing
hypotheses suggest the function of sleep is restorative, conservative, and
adaptive (Tononi and Cirelli 2006; Chokroverty 2010).

To investigate the

relationship between TBI and acute sleep, the current study uses gentle handling
to disrupt sleep after mFPI, an animal model of concussion (Dixon et al. 1987).
Following mFPI, with and without sleep disruption, mice can be evaluated for
performance in cognitive, neurological, and motor function, using standard
behavioral tests (Nakamura et al. 1999; Longhi et al. 2004; Schoch et al. 2012).
Our previous findings indicated an increase in sleep during the first six
hours following diffuse brain injury in mice—a period we have defined as posttraumatic sleep (Rowe et al. 2013c). During this period brain-injured mice are
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responsive, capable of movement, and eat and groom themselves, indicating
they are not in a comatose state of unresponsiveness. Following TBI, secondary
injury processes are triggered including the production of cytokines, some of
which have dual roles as sleep regulatory substances (SRSs) (Krueger and
Majde 1995; Krueger et al. 2007; Krueger 2008). Similar increases in cytokine
signaling have been observed across experimental models and in human TBI,
highlighting their involvement in pathological and reparative processes triggered
by injury (Morganti-Kossmann et al. 2001; Frugier et al. 2010; Semple et al.
2010; Ziebell and Morganti-Kossmann 2010). The increases in sleep promoting
cytokines suggest post-traumatic sleep is a natural process. Whether this natural
process is beneficial to functional outcome remains to be seen.
Clinical recommendations and at home practices with regard to sleep after
TBI cover an array of interventions including total deprivation, frequent
awakening, and encouraging sleep. Experimentally, multiple techniques can
disrupt or deprive sleep. Sleep deprivation is the complete disruption of one or
both types of sleep (rapid eye movement (REM), non-rapid eye movement
(NREM)), compared to sleep disruption in which minimal sleep may occur.
Deprivation of REM sleep can be achieved using methods that operate when
muscle tone is lost as REM sleep begins. In these methods, muscle tone is
required for an animal to balance on a platform in water; with the onset of atonia,
the animal would fall off the platform into water and wake the animal. Frequently
used REM deprivation methods include the flower pot and variations of the
multiple platform method (Cohen and Dement 1965), which may also
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compromise slow wave sleep (SWS) (Machado et al. 2004). Acute injury-induced
motor deficits prevented the use of these deprivation methods. Thus, total
disruption of post-traumatic sleep was implemented, allowing only minimal sleep
during the disruption period. Experimental methods for disrupting sleep include
forced wheel running and gentle handling. Investigations have shown forced and
voluntary exercise can positively and negatively affect behavioral and histological
outcomes following brain injury (Zhang et al. 2010; Griesbach 2011; Crane et al.
2012; Griesbach et al. 2012; Yang et al. 2012b; Silva et al. 2013). To disrupt
sleep, we used the gentle handling method along with cage tapping whenever
animals began falling asleep (Patti et al. 2010), which disrupts all stages of sleep.
We are extending our investigations into sleep as a natural response to
TBI. Increased post-traumatic sleep, paired with inconsistent recommendations
for sleep after TBI, make understanding the role of post-traumatic sleep an
important public health concern. Understanding the impact of post-traumatic
sleep on functional outcome could inform home care recommendations for the
large number of TBI survivors not seeking medical attention. We hypothesize that
post-traumatic sleep disruption would result in poor functional outcome following
TBI. To test this hypothesis, we used mFPI to model diffuse TBI in mice,
disrupted post-traumatic sleep for six hours post-injury, and assessed cognitive,
motor and sensorimotor functional outcome over one week post-injury. The goal
of this study is to add knowledge for evidence-based clinical recommendations in
the treatment of mild TBI.
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Methods
Animals
Male C57BL/6 mice (Harlan Laboratories, Inc., Indianapolis, IN) were used
for all experiments (n=109). The animals were housed in a 12 h light/12h dark
cycle at a constant temperature (23°C ± 2° C) with food and water available ad
libitum according to the Association for Assessment and Accreditation of
Laboratory Animal Care International. Animals were acclimated to their
environment following shipment for at least three days prior to any experiments.
After surgery, animals were evaluated daily for post-operative care by a physical
examination and documentation of each animal’s condition. Animal care was
approved by the Institutional Animal Care and Use Committees at the University
of Kentucky and the St. Joseph’s Hospital (Phoenix, AZ).
Housing
All mice used in this study were singly housed. Mice used for the MWM
and NOR studies were housed in standard individually ventilated cages. Mice for
all other studies were housed in the non-invasive sleep-monitoring cage system
(Signal Solutions, Lexington, KY).
Midline Fluid Percussion Injury (mFPI)
Mice (20-24g) were subjected to midline fluid percussion injury (mFPI)
consistent with methods previously described (Lifshitz 2008). Animal numbers
are indicated in the results section and figure legends for individual studies. Mice
were anesthetized using 5% isoflurane in 100% oxygen for five minutes and the
head of the animal was placed in a stereotaxic frame with continuously delivered
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isoflurane at 2.5% via nosecone. While anesthetized, the animal’s body
temperature was maintained using a Deltaphase® isothermal heating pad
(Braintree Scientific Inc., Braintree, MA). A midline incision was made exposing
bregma and lambda, and fascia was removed from the surface of the skull. A
trephine (3 mm outer diameter) was used for the craniotomy, centered on the
sagittal suture between bregma and lambda without disruption of the dura. An
injury cap prepared from the female portion of a Luer-Loc needle hub was fixed
over the craniotomy using cyanoacrylate gel and methyl-methacrylate (Hygenic
Corp., Akron, OH). The incision was sutured at the anterior and posterior edges
and topical Lidocaine ointment was applied. The injury cap was closed using a
Luer-Loc cap and animals were placed in a heated recovery cage and monitored
until ambulatory before being returned to their sleep cage.
For injury induction 24 hours post-surgery, animals were re-anesthetized
with 5% isoflurane delivered for five minutes. The cap was removed from the
injury-hub assembly and the craniotomy was visually inspected through the hub.
The hub was then filled with normal saline and attached to a tube connected to
the male end of the fluid percussion device (Custom Design and Fabrication,
Virginia Commonwealth University, Richmond, VA). An injury of moderate
severity (1.4 atm) was administered by releasing the pendulum onto the fluidfilled cylinder. Sham-injured animals underwent the same procedure except the
pendulum was not released. Animals were monitored for the presence of a
forearm fencing response and righting reflex times were recorded for the injured
animals as indicators of injury severity (Hosseini and Lifshitz 2009). The righting
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reflex time is the total time from the initial impact until the animal spontaneously
rights itself from a supine position. The fencing response is a tonic posturing
characterized by extension and flexion of opposite arms that has been validated
as an overt indicator of injury force magnitude (Hosseini and Lifshitz 2009). The
injury hub was removed and the brain was inspected for uniform herniation and
integrity of the dura. Animals in which the dura was compromised were excluded
from all studies as technical failures. The incision was cleaned using saline and
closed using sutures. Moderate brain-injured animals had righting reflex recovery
times greater than six minutes and a positive fencing response. Sham injured
animals recovered within 20 seconds. After spontaneously righting, animals were
placed in a heated recovery cage and monitored until ambulatory (approximately
5 to 15 minutes) before being returned to their sleep cage or subjected to sleep
disruption. Adequate measures were taken to minimize pain or discomfort.
Sleep Disruption
Mice were randomly assigned to a sleep disruption or no sleep disruption
group. The mice in the no sleep disruption group were returned to their individual
cages as soon as they were ambulatory (approximately 5 to 15 minutes)
following the brain injury or sham injury. Mice in the sleep disruption group were
placed in individual cages and continuously sleep disrupted for six hours postinjury, the duration over which the mFPI mice sleep in excess of sham controls,
as previously observed in our model (Rowe et al. 2013c). Sleep disruption was
accomplished using a minimally stressful gentle handling method (O'Hara et al.
1993; Asikainen et al. 1995; Patti et al. 2010), which included tapping on the
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cages or gently touching the animal when visible signs (immobile, eyes closed) of
sleep were present (Patti et al. 2010). After the disruption period, mice were
returned to their individual cages and sleep activity was measured continuously
for 24 hours (see below).
Sleep Recordings
The non-invasive sleep cage system (Signal Solutions, Lexington, KY)
used in this study consisted of 16 separate units that could simultaneously
monitor the sleep and wake states, as previously published (Rowe et al. 2013c).
Each cage unit housed a single mouse inside 7x7 inch walled compartments with
attached food and water structures (Donohue et al. 2008). The cages had open
bottoms resting on Polyvinylidine Difluoride (PVDF) sensors serving as the cage
floor (Donohue et al. 2008). The non-invasive high-throughput PVDF sensors
were coupled to an input differential amplifier and pressure signals were
generated and classified by an algorithm (see below) as motions consistent with
either wake activity or the inactivity and regular breathing movements associated
with sleep (Donohue et al. 2008). Briefly, sleep was characterized primarily by
periodic (3 Hz) and regular amplitude signals recorded from the PVDF sensors,
typical of respiration from a still mouse. In contrast, signals characteristic of wake
were both the absence of characteristic sleep signals and higher amplitude,
irregular spiking associated with volitional movements. The piezoelectric signals
in two second epochs were classified by a linear discriminant classifier algorithm
based on frequency and amplitude to assign a binary label of “sleep” or “wake”
(Donohue et al. 2008). Mice sleep in a polycyclic manner (more than 40 sleep
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episodes per hour) (McShane et al. 2010). For experimental studies, mouse
sleep was quantified as the minutes spent sleeping per hour, presented as a
percentage for each hour. Sleep activity data were binned over specified time
periods (e.g. 5 minutes, 1 hour) to calculate the average of percent sleep. Data
were binned by length of individual sleep bouts to calculate median bout length.
Corticosterone assay
Immediately following six hours of sleep disruption, mice were euthanized
(between 14:00 and 17:00), by an overdose of sodium pentobarbital, and a
cardiac blood sample was collected (sham n=2, injury n=4). A separate group of
animals was not exposed to sleep disruption prior to blood collection (sham n=2,
injury n=4). The blood samples were centrifuged (3000 rpm, 8 min) and the
serum was stored at -20ºC. A commercially available competitive immunoassay
was followed according to the manufacturer’s protocol for the quantitative
determination of corticosterone (no. 900-097; Assay Designs, Inc. Ann Arbor,
MI). The kit uses an anti-corticosterone polyclonal antibody to bind standards and
samples. The enzyme reaction generates a yellow color that is inversely
proportional to the corticosterone concentration and is read on a microplate
reader (405 nm). All samples were diluted 1:5 (80%) in order to stay within the
sensitivity of the assay (32–20,000 pg/ml). Data are presented as levels of serum
corticosterone concentration in nanograms/milliliter.
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Behavioral Testing
Behavioral testing was performed on two cohorts of animals. One cohort was
tested on the rotarod and neurological severity score. A separate cohort was
tested by novel object recognition and the Morris water maze.
Neurological Severity Score (NSS). Post-traumatic neurological impairments were

assessed using an 8-point NSS paradigm adapted from those previously used in
experimental models of TBI (Chen et al. 1996; Semple et al. 2010; Pleasant et al.
2011; Ziebell et al. 2011). Animals were tested at selected time points post-injury
(1, 3, 5, 7 days). One point was given for failure on an individual task, and no
points were given if an animal completed a task successfully. Mice were
observed for hind limb flexion, startle reflex, and seeking behavior (presence of
these behaviors was considered successful task completion). Mice traversed in
sequence, 3, 2, and 1 centimeter beams. The beams were elevated and mice
were given 1 minute to travel 30 centimeters on the beams. The task was scored
as a success if the mouse traveled 30 centimeters with normal forelimb and
hindlimb position (forelimb/hindlimb did not hang from the beam). Mice were also
required to balance on a 0.5 centimeter beam and a 0.5 centimeter round rod for
3 seconds in a stationary position with front paws between hind paws. Nonparametric data are presented as a composite score ranging from 1 to 8
representing performance on all tasks combined. High final NSS scores were
indicative of task failure and interpreted as neurological impairment.
Rotarod. Sensorimotor function was assessed using the Economex Rotarod
system from Columbus Instruments (Columbus, OH). Animals were pre-trained
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(60 sec at 4 rpm for 3 trials) for three consecutive days including the day of the
craniotomy. Animals were then tested at selected time points post-injury. Animals
were tested either immediately and 1 hour after injury or tested on post-injury
days 1, 3, 5, and 7. For the test, animals were placed on the rod with a starting
speed of 4 rpm, and the speed was continuously accelerated up to 28 rpm over 5
minutes (for 2 trials), as previously published (Bachstetter et al. 2013). The trial
ended when the mouse fell from the rod or 5 minutes elapsed. Data are
presented as latency to fall in seconds and total distance traveled in centimeters.
Morris Water Maze (MWM). Learning ability was assessed in the MWM using a
paradigm similar to those previously used in experimental models of TBI (Smith
et al. 1995; Murai et al. 1998; Smith et al. 1998; Prins and Hovda 2001; Pleasant
et al. 2011). The 1-meter diameter MWM was filled with water (19-21°C) and
nontoxic white paint (Rich Art Co., Northvale, NJ) was added to hide the platform
(6.3 centimeter diameter) that was submerged 0.5 centimeters. At selected time
points post-injury (3, 4, 5, 6 days), mice were tested in sets of four trials per day.
Mice started from one of four starting points (North, South, East, West) and used
visual cues placed on the walls outside the tank to locate the platform. All trials
were monitored using overhead video/tracking software (EZVideo version
5.51DV, Accuscan Instruments Inc., Columbus, OH). The latency of the mouse to
find the platform was recorded as well as the distance traveled. If a mouse did
not find the platform within the 70 second trial, it was placed on the platform for
10 seconds. Data are presented as latency to find the hidden platform in
seconds.
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Novel Object Recognition (NOR). Cognitive impairment was tested using the
NOR test as previously published (Ennaceur and Aggleton 1997; Han et al.
2011). The test consisted of three phases: habituation, training, and testing. On
day 3 post-injury, mice were placed in an open field (42 cm, 21 cm, 21 cm) for
one hour of habituation. Mice were removed and two identical objects were
placed in opposing quadrants of the field for the training phase. Mice were placed
in the center of the open field and given 5 minutes to explore the objects.
Following training mice were returned to their home cages. Testing began 4
hours after training. One familiar object and one novel object were placed in
opposing quadrants of the field. Mice were placed into the center and given 5
minutes to explore. On day 7 post-injury, mice were given 10 minutes of
habituation to their previously used open field. After habituation, mice were
removed and the familiar object from training and a novel object (distinct from the
object on day 3) were placed in opposing quadrants of the field and mice were
given 5 minutes to explore. For training and testing the percentage of time spent
exploring the novel object was quantified. Exploration of an object included the
mice sniffing, touching, or climbing onto an object while facing the object. If an
animal climbed onto an object and sniffed into the air, this time was not
calculated into the exploration of the novel object. During training and testing
trials, mice were required to spend a minimum combined 10 seconds exploring
objects. If this time was not met, trial time was extended for that animal until 10
seconds of exploration was achieved (sham: 1 of 12, 30 sec; FPI: 5 of 24, mean
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61 ± 17.5 sec). Data are presented as percent of total exploration time spent
exploring the novel object.
Statistical Analysis
Data are shown as mean ± SEM and analyzed using statistical software
(GraphPad-Prism 6). Differences in righting reflex times were determined by ttest. Differences in rotarod performance immediately following TBI were
determined with a repeated measure two-way analysis of variance (ANOVA)
followed by Sidak’s multiple comparison test. Percent sleep following disruption
was analyzed using a repeated measure two-way ANOVA. Differences in
rebound sleep were determined using a one-way ANOVA followed by Tukey’s
post-hoc analysis. Differences in functional performance over time post-injury
measured by the rotarod, MWM, and NOR were all determined using a two-way
ANOVA, followed by Tukey’s post-hoc analysis as needed. Non-parametric NSS
data were analyzed by Kruskal-Wallis ANOVA, followed by Dunn’s comparison
post-hoc test (see results). Statistical significance was assigned when p<0.05.
Results
Immediate neurological deficits following diffuse TBI.
We have previously reported a suppression of the righting reflex response
in rats following mFPI (Hosseini and Lifshitz 2009), as an injury-induced deficit.
Diffuse brain injury resulted in a significant suppression of the righting reflex in
brain-injured mice compared to anesthetized, uninjured shams (t31=3.351,
p=0.0021; sham n=28, injury n=33; Figure 4.1A). To assess acute vestibulomotor
deficits following diffuse TBI, we used the rotarod task immediately and 1 hour
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after the return of the righting reflex (Fox et al. 1998; Hamm 2001; Laurer et al.
2001). There was a significant injury-dependent motor deficit measured by
latency on the Rotarod task in brain-injured mice compared to uninjured shams
(F(1, 11)=83.93, p<0.0001; Figure 4.1B) both immediately and 1 hour after return
of the righting reflex (sham n=6, injury n=7; Figure 4.1B).
Intentional sleep disruption following diffuse TBI did not result in a
rebound of lost sleep but alters activity response to dark-onset.
Corticosterone levels were measured at the conclusion of the six hour
disruption period as an indicator of stress related to the sleep disruption. Sleep
disruption did not significantly alter corticosterone levels in cardiac blood samples
in either sleep disruption shams or sleep disruption injured mice impaired to no
disruption shams and no disruption brain-injured mice (Figure 4.2A). Braininjured mice had significantly lower levels of corticosterone compared to
uninjured shams regardless of sleep disruption at the conclusion of the testing
period (F(1,8)=7.57, p=0.0250; Figure 4.2A). As intended, the sleep disruption
method developed for these studies did not adversely impact corticosterone
levels.
Following six hours of intentional sleep disruption, using the gentle
handling method (Patti et al. 2010), there was no significant change in percent
sleep over six hours between sleep disruption brain-injured and sleep disruption
shams compared to no disruption brain-injured and no disruption shams (F(3,
32)=2.187, p=0.1087; no disruption sham n=7, no disruption injury n=8, sleep
disruption sham n=8, sleep disruption injury n=13; Figure 4.2B). This indicated
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that the sleep lost during the six hours of intentional disruption was not recovered
by the sleep disrupted groups, at least in terms of total sleep time. However,
there was a sleep disruption effect on activity response to dark-onset at 10h postinjury (19:00) (F(3, 32)=0.9386, p=0.0024; Figure 4.2C). There was a significant
difference between no disruption sham compared to both sleep disruption braininjured and sleep disruption sham mice (Figure 4.2C). Both the sleep disrupted
brain-injured and sleep disrupted shams slept significantly more following darkonset compared to the no disruption brain-injured and no disruption shams. In
the absence of sleep disruption, uninjured and brain-injured animals showed
increased wake activity following dark onset, as is typical for nocturnal rodents.
Diffuse TBI resulted in neurological impairments independent of acute
sleep disruption.
Overall, brain-injured mice showed significant neurological impairments
measured by the neurological severity score (NSS) compared to uninjured
shams, independent of sleep disruption (no disruption sham n=12, no disruption
injury n=13, sleep disruption sham n=10, sleep disruption injury n=13; Figure
4.3). On post-injury days 1, 3 and 5, both sham groups had significantly lower
NSS scores compared to both brain-injured groups (Day 1 KW(4,48)=27.45,
p<0.0001; Day 3 KW(4,48)=18.99, p=0.0003; Day 5 KW(4,48)=15.63, p=0.0013;
Day 7 KW(4,48)=16.36, p=0.001; Kruskal-Wallis statistic with Dunn’s comparison
post-hoc; Figure 4.3). There was no significant difference in neurological
impairments measured by the NSS between the sleep disruption brain-injured
mice and no disruption brain-injured mice at any post-injury time point.
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Diffuse TBI reduced motor performance on the rotarod task independent of
acute sleep disruption.
To assess motor function we used the rotarod task as previously
published (Bachstetter et al. 2013). Following diffuse brain injury, there was a
significant injury-dependent effect on latency to stay on the rotarod (F(3,
44)=3.367, p=0.0268) and a time-dependent improvement in latency (F(3,
132=41.60, p<0.0001; Figure 4.4A; no disruption sham n=12, no disruption injury
n=13, sleep disruption sham n=10, sleep disruption injury n=13). There was a
significant injury and disruption effect on rotarod latency between sleep
disruption brain-injured mice compared to no disruption sham on post-injury day
7 (Figure 4.4A). There was no significant difference in latency on the rotarod task
between the sleep disruption brain-injured mice and no disruption brain-injured
mice (F(1,24)=0.5033, p=0.4849). Further analysis of rotarod performance
showed a significant injury-dependent effect on distance traveled (F(3,
44)=4.009, p=0.0132) and a time-dependent improvement in distance traveled
(F(3, 132)=34.61, p<0.0001; Figure 4.4B). There was a significant injury effect
between no disruption sham compared to both injury groups (no disruption and
sleep disruption) on post-injury day 5 and 7. There was no significant difference
in distance traveled on the rotarod task between the sleep disruption braininjured mice and no disruption brain-injured mice (F(1,24)=0.2592, p=0.6154).
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Acute sleep disruption following diffuse TBI did not alter cognitive
performance.
Performance on the Morris water maze task indicated all groups had a
significant time-dependent improvement in latency to find the hidden platform
(F(3, 96)=17.40, p<0.0001; Figure 4.5; no disruption sham n=6, no disruption
injury n=12, sleep disruption sham n=6, sleep disruption injury n=12). There was
no significant injury-dependent effect or sleep disruption effect on cognitive
performance measured by latency to find the platform at the selected acute postinjury time points (days 3, 4, 5, 6). Performance on the novel object recognition
task showed no significant injury-dependent effect or sleep disruption effect on
recall of the familiar object at the selected acute post-injury time points (days 3,
7). All groups showed significant increase in novel object exploration at 3 days
post-injury compared to training (F(2,64)=15.61, p<0.001; Figure 4.6; no
disruption sham n=6, no disruption injury n=12, sleep disruption sham n=6, sleep
disruption injury n=12). There was no significant injury effect or sleep disruption
effect on novel object recognition.
Discussion
In the diffuse brain-injured mouse, immediate disruption of post-traumatic
sleep does not worsen injury-induced motor or cognitive deficits. Our previous
studies showed a significant increase in percent sleep of brain-injured mice
compared to uninjured shams over the first six hours following diffuse TBI (Rowe
et al. 2013c). Disrupting the six hours of post-traumatic sleep was hypothesized
to worsen functional outcome after midline fluid percussion injury, because sleep,
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in general, is reparative and restorative (Walker et al. 2005; Tononi and Cirelli
2006; Sheth et al. 2008; Cohen et al. 2009; Chokroverty 2010). In the current
study, we show that gentle handling for six hours post-injury to disrupt sleep had
no effect on stress measured by corticosterone levels at the end of the disruption
period and did not result in rebound of lost sleep or worsened functional
outcome. It remains possible that sleep disruption lead to an early surge in
corticosterone, which was missed by measuring after six hours of disruption,
regardless without functional consequences. Anesthetics used at the time of
serum collection may have also contributed to alterations in corticosterone
(Jacobsen et al. 2012). Our data provide the first evidence that sleep disruption
(immediate, short duration) does not affect functional outcome following diffuse
brain injury in mice.
Currently, investigations into acute sleep disruption after TBI are lacking,
despite the common practice of disturbing sleep acutely following a concussion.
Previous attempts to investigate sleep disruption as a neuroprotective
intervention following TBI have been presented in short communication, but
methodological issues compromise the interpretation of the data (MartinezVargas et al. 2012). Following ischemia, however, acute intervention has been
shown to be neuroprotective in the rat (Lay et al. 2010). Whisker stimulation in
the immediate post-infarct period (within the first hour) can protect the cortex,
suggesting a role for cortical activation through sensory stimulation in
determining outcome following middle cerebral artery occlusion (Lay et al. 2010).
Contradictory data after focal cerebral ischemia in the rat show that sleep
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deprivation for 12 hours using a gentle handling protocol increased infarct area
(Gao et al. 2010). Also, sleep disturbance (12 hours a day for three consecutive
days) following focal cerebral ischemia in the rat worsened behavioral outcome
assessed using the single pellet reaching test through 35 days post-ischemia
(Zunzunegui et al. 2011). The findings of these studies suggest a role of sleep
modulating recovery processes following stroke (Gao et al. 2010; Zunzunegui et
al. 2011). Thus, sleep disturbance immediately following ischemia can worsen
outcome, but activating discrete circuits through whisker stimulation can be
neuroprotective (Gao et al. 2010; Lay et al. 2010; Zunzunegui et al. 2011),
suggesting that additional systemic effects of behavioral sleep deprivation (e.g.
elevated temperature and blood pressure) may counteract protective effects of
local circuit activation. In this study, we pursued sleep disruption in a clinically
relevant manner to model the acute period of post-traumatic sleep disruption and
found limited impact on functional outcome.
In midline fluid percussion, injury-induced histopathology is uncomplicated
by contusion, cavitation, or overt hemorrhage (Povlishock and Katz 2005;
McGinn et al. 2009) and microscopically the injury is characterized by traumatic
axonal and vascular injury (Singleton et al. 2002; Kelley et al. 2006; Farkas and
Povlishock 2007; Greer et al. 2011; Greer et al. 2012; Greer et al. 2013). Diffuse
brain injury also leads to significant changes in behavioral and histological
outcome (Semple et al. 2010; Bachstetter et al. 2013). We have previously
shown that TBI increases sleep in mice over the first six hours post-injury
regardless of injury severity (Rowe et al. 2013c). Since our previous data show
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that mild and moderate diffuse TBI result in equivalent increases in sleep, the
current study did not include mild TBI. Sleep bouts in brain-injured mice are
longer in duration than in uninjured mice (Rowe et al. 2013c). Our previous report
of the raw data produced by the non-invasive sleep monitoring cages showed
sleep was interrupted by high amplitude and frequency signals corresponding to
volitional movement in both brain-injured mice and uninjured shams (Rowe et al.
2013c). Interruptions of sleep bouts by volitional movement indicate the braininjured animals terminate sleep bouts in a similar manner to uninjured mice,
suggesting that brain-injured mice are responsive, capable of movement, and not
in a comatose state of unresponsiveness.
For our method of sleep disruption, we used gentle handling to continually
disrupt sleep for six hours. Immediate motor deficits following our diffuse injury
model (Figure 4.1) make it impractical to use the flower pot or multiple platform
method for sleep disruption, because the brain-injured animals cannot perform
the task (i.e. balance on the flower pot). Previous studies have shown forced and
voluntary exercise can positively and negatively affect behavioral and histological
outcomes following brain injury (Zhang et al. 2010; Griesbach 2011; Crane et al.
2012; Griesbach et al. 2012; Yang et al. 2012b; Silva et al. 2013) and for this
reason, animals were not disrupted with forced wheel running. For example,
treadmill exercise following fluid percussion injury in the rat reduced injuryinduced seizures but did not protect against neuronal injury (Silva et al. 2013).
Similarly, voluntary wheel running following medial frontal cortical contusions in
rats exacerbated TBI-induced deficits (Crane et al. 2012). Our data also indicate
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that our method of sleep disruption did not significantly alter stress levels, as
indicated by stable corticosterone levels at the conclusion of the disruption
period. Corticosterone, a glucocorticoid, is released following stress and
exposure to high level glucocorticoids may affect brain plasticity and recovery
(Sapolsky and Pulsinelli 1985; McEwen 2008). To this end, a sleep disruption
protocol minimized stress and thereby impact on outcomes.
Immediately following the six hour disruption period, percent sleep was
measured to determine whether sleep-disrupted mice displayed a rebound of lost
sleep. A previous study using a similar sleep disruption protocol for six hours
prior to ischemia in rats showed a significant rebound of sleep in the dark cycle
following insult (Cam et al. 2013). Sleep was disrupted prior to insult to test if
sleep rebound is neuroprotective after ischemia. However, in the present studies
sleep disrupted mice did not show a rebound in sleep to compensate for the loss
of six hours of sleep. Despite the lack of rebounded sleep, short-term disruption
was insufficient to adversely affect outcome. It is likely that both rodent and man
can recover from transient sleep disruption after brain injury without significant
functional consequence. Sleep disruption prior to injury or for longer durations
could worsen outcome.
Clinical data suggest injury-induced circadian rhythm disturbances may
contribute to the pathophysiological sequelae of TBI (Ayalon et al. 2007; Paul
and Lemmer 2007; Castriotta and Murthy 2011) and inhibit neurogenesis,
potentially compromising recovery (Meerlo et al. 2009). Lateral fluid percussion
injury has been shown to alter circadian clock gene expression without producing
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injury-dependent changes in activity during the first dark cycle post-injury (Boone
et al. 2012). Similarly, in our study, we did not observe injury-dependent changes
in activity during the first dark cycle. However, sleep disrupted brain-injured and
uninjured shams exhibit a delayed activity response during the hour following the
first dark-onset post-injury (10 hours post-injury), sleeping significantly more than
non-sleep disrupted mice. Sleep disrupted mice slept 10-20% more during this
hour, amounting to 6-12 minutes more sleep than the non-sleep disrupted mice.
Sleep patterns of the disrupted mice become indistinguishable from the nondisrupted mice by the first light onset (data not shown).
We found that sleep disruption immediately following brain injury did not
affect functional outcome. It has been previously shown that experimental diffuse
TBI results in significant motor impairment (Bachstetter et al. 2013; Yang et al.
2013). We observed injury-induced sensorimotor impairments measured with the
rotarod and neurological severity score tests. Acute sleep disruption, however,
neither exacerbated nor attenuated the injury-induced deficits. In our literature
evaluation, we found no published reports on the impact of acute sleep disruption
on sensorimotor performance in mice.
Similarly, diffuse TBI in mice has been shown to significantly impair
cognition as early as two days post-injury with deficits lasting as long as 90 days
post-injury (Zohar et al. 2011; Yang et al. 2013). However, cognitive outcome
measures in mice following midline fluid percussion injury have not been
previously reported. No cognitive impairment following diffuse TBI was measured
using the Morris water maze or novel object recognition task, within the first week
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post-injury. Following sleep disruption there was no significant change in
cognitive performance. It has previously been reported that learning in the MWM
is not impacted by six hours of rapid eye movement sleep deprivation (Walsh et
al. 2011). Also, sleep disruption before acquisition had no effect on spatial
learning and memory components of rodent cognition (Hagewoud et al. 2010;
Yang et al. 2012a). These findings are in line with our data indicating six hours of
sleep disruption did not alter cognitive function.
Taken together, our data indicated that acute sleep disruption following
diffuse TBI did not worsen functional outcome, which precluded further analysis
of cellular repair benefits of sleep. These results were not unexpected, since
previous studies have reported that six hours of sleep disruption did not impact
functional outcome independent of brain-injury (Hagewoud et al. 2010; Walsh et
al. 2011). A possible limitation of this study was the disruption of post-traumatic
sleep only. Extending the duration of sleep disruption may negatively affect
outcome, however, chronic sleep disruption would reduce clinical relevance for
the large at-home, non-medically treated population. To address the controversy
of whether non-hospitalized individuals should sleep or be frequently awoken
following TBI, six hours of sleep disruption following TBI is translationally
relevant. Further investigation is needed to determine the impact of sleep
disruption on other aspects of post-traumatic symptomology including somatic
and emotional function.
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Conclusion
In conclusion, the current study demonstrated that disrupting acute posttraumatic sleep following diffuse TBI did not worsen functional outcome. The
sleep lost during the disruption period was not recovered by increased sleep
time, and there were no long lasting circadian disturbances detected under 12:12
light:dark conditions. Further studies are needed to fully understand the cellular
benefit or detriment, if any, of acute post-traumatic sleep on recovery following
TBI, as well as other neurological conditions.
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Chapter Four: Figures

Figure 4.1 Diffuse TBI led to immediate neurological deficits.
(A) Immediately following experimental diffuse TBI in mice there was significant
suppression of the righting reflex (mean ±SEM; t(31)=3.351, p=0.0021; sham
n=28, injury n=33). (B) Immediately following diffuse TBI there was a significant
motor deficit measured by latency in the Rotarod task. A repeated-measure two-
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way ANOVA showed a significant decrease in latency on the Rotarod in braininjured mice compared to uninjured shams (mean ±SEM; F(1, 11)=83.93,
p<0.0001). Sidak’s multiple comparison test showed a significant difference
between brain-injured mice compared to uninjured shams both immediately after
injury, and 1 hour after injury (*, p<0.05; sham n=6, injury n=7).
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Figure 4.2 Intentional sleep disruption following diffuse TBI did not result in
altered corticosterone levels or a rebound of lost sleep but altered activity
response to dark-onset.
(A) Sleep disruption for six hours following diffuse TBI did not alter levels of
corticosterone in cardiac blood samples. In both no disruption and sleep
disruption groups the brain-injured mice had significantly lower levels of
corticosterone compared to uninjured shams (mean +SEM; F(1,8)=7.57,
p=0.0250). There was no significant difference between sleep disruption and no
disruption groups. (B) Following six hours of intentional sleep disruption (see
methods), a two-way ANOVA showed no significant change in percent sleep
between groups (mean ±SEM; F(3, 32)=2.187, p=0.1087) indicating no rebound
of lost sleep. Bar indicates light/dark transition. Box in panel B is enlarged in
panel C. (C) At dark-onset, a one-way ANOVA showed an effect of sleep
disruption (mean ±SEM; F(3, 32)=0.9386, p=0.0024). Tukey’s post-hoc test
indicated a difference between no disruption sham compared to both sleep
disruption brain-injured and sleep disruption sham mice (*, p<0.05; no disruption
sham n=7, no disruption injury n=8, sleep disruption sham n=8, sleep disruption
injury n=13).
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Figure 4.3 Diffuse TBI resulted in neurological impairments independent of
acute sleep disruption.
Overall,

brain-injured

mice

showed

significant

neurological

impairments

measured by the neurological severity score compared to uninjured shams
independent of sleep disruption. Sleep disruption shams showed a significantly
lower NSS score compared to both injury groups (sleep disruption injury, no
sleep disruption injury) on post-injury days 1,3 and 5 (*; p<0.05). On post-injury
day 7, sleep disruption shams had a significantly lower NSS score compared to
sleep disruption brain-injured mice (*; p<0.05). No disruption shams had a
significantly lower NSS score compared to both injury groups (sleep disruption
injury, no disruption injury) on post-injury days 1 and 7 (#; p<0.05). No disruption
shams had significantly lower NSS scores compared to no disruption braininjured mice on post injury days 3 and 5 (#; p<0.05). See results for statistics. (no
disruption sham n=12, no disruption injury n=13, sleep disruption sham n=10,
sleep disruption injury n=13).
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Figure 4.4 Diffuse TBI altered motor performance on the rotarod task
independent of acute sleep disruption.
(A) A two-way ANOVA showed a significant injury-dependent effect on latency to
stay on the rotarod (mean ±SEM; F(3, 44)=3.367, p=0.0268) and a timedependent improvement in latency (mean ±SEM; F(3, 132=41.60, p<0.0001).
Tukey’s post-hoc test indicated a difference between sleep disruption braininjured mice compared to no disruption sham on post-injury day 7 (*, p<0.05).
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There was no significant difference in latency on the rotarod task between the
sleep disruption brain-injured mice and no disruption brain-injured mice
(F(1,24)=0.5033, p=0.4849). (B) A two-way ANOVA showed a significant injurydependent effect on distance traveled (mean ±SEM; F(3, 44)=4.009, p=0.0132)
and a time-dependent improvement in distance traveled (mean ±SEM; F(3,
132)=34.61, p<0.0001). Tukey’s post-hoc test indicated a difference between no
disruption sham compared to both injury groups (no disruption and sleep
disruption) on post-injury day 5 and 7 (*, p<0.05). There was no significant
difference in distance traveled on the rotarod task between the sleep disruption
brain-injured mice and no disruption brain-injured mice (F(1,24)=0.2592,
p=0.6154). (no disruption sham n=12, no disruption injury n=13, sleep disruption
sham n=10, sleep disruption injury n=13).
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Figure 4.5 Acute sleep disruption following diffuse TBI did not alter
cognitive performance on the Morris water maze (MWM) or novel object
recognition (NOR) tasks.
(A) A two-way ANOVA showed a significant time-dependent improvement in
latency to the platform (mean ±SEM; F(3, 96)=17.40, p<0.0001). There was no
significant injury-dependent effect or sleep disruption effect on cognitive
performance at the selected acute post-injury time points. (no disruption sham
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n=6, no disruption injury n=12, sleep disruption sham n=6, sleep disruption injury
n=12). (B) There was no significant injury-dependent effect or sleep disruption
effect on cognitive performance at the selected acute post-injury time points. All
groups showed a time-dependent learning of the familiar object (mean ±SEM;
F(2,64)=15.61, p<0.001). There was no significant injury effect or disruption
effect. (no disruption sham n=12, no disruption injury n=13, sleep disruption
sham n=10, sleep disruption injury n=13).
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Preface to Chapter Five
In the previous chapters, we showed an injury-induced increase in
immediate post-traumatic sleep and demonstrated disrupting this post-traumatic
sleep does not worsen functional outcome. The experiments in Chapter Five
investigated the effect of acute administration of over-the-counter analgesics on
neurological function, acute sleep profiles, and cortical cytokine levels after
experimental diffuse TBI in the mouse. A one-time dose was given to replicate
clinical settings in which a person sustains a concussion and treats immediate
pain as a symptom of injury. Overall, we showed immediate pharmacological
intervention did not attenuate or exacerbate TBI-induced functional deficits, but
altered sleep profiles. These data may inform clinical recommendations for the
at-home treated mildly concussed patient. A more comprehensive outline of the
effects of drug intervention on TBI has been included in the Appendix.
Chapter Five: Acute over-the-counter pharmacological intervention does
not adversely affect behavioral outcome following diffuse traumatic brain
injury in the mouse
Summary
Survivors of mild TBI often do not seek medical attention and may selftreat symptoms of concussion, including post-traumatic headache, by taking
over-the-counter (OTC) analgesics. Common OTC analgesic medicines have
varying anti-inflammatory properties which could impact acute functional
outcomes thought to be related to inflammation, including neurological function
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and post-traumatic sleep. Administering one dose of OTC analgesics
immediately following experimental brain injury mimics the at-home treated
population of concussed patients and may accelerate the understanding of the
relationship between brain injury and OTC pharmacological intervention. In the
current study, we investigate the effect of acute administration of OTC analgesics
on neurological function, acute sleep profiles, and cortical cytokine levels after
experimental diffuse TBI in the mouse.
Adult, male C57BL/6 mice were injured using a midline fluid percussion
mFPI injury model of concussion (6-10 min righting reflex time for brain-injured
mice). Experimental groups included mFPI paired with either ibuprofen (60mg/kg,
i.p.; n=16), acetaminophen (40mg/kg, i.p.; n=9), or vehicle (15% ethanol (v/v) in
0.9% saline; n=13) and sham injury paired OTC medicine or vehicle (n=7-10 per
group). At 24 hours after injury, functional outcome was assessed using the
rotarod task and a modified neurological severity score (NSS), and then related
back to acute sleep profiles. Following behavior assessment, cortical cytokine
levels were measured by multiplex ELISA. In the diffuse brain-injured mouse,
immediate pharmacological intervention did not attenuate or exacerbate TBIinduced functional deficits, but altered sleep profiles. Cortical cytokine levels
were not affected by injury or treatment at 24 hours post-injury. These data
indicate acute administration of OTC analgesics did not exacerbate or attenuate
brain-injury deficits which may inform clinical recommendations for the at-home
treated mildly concussed patient.
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Introduction
TBI is a major cause of death and disability throughout the world (Langlois
et al. 2006; Reilly 2007; Roozenbeek et al. 2013). In the United States between
2002 and 2006, the Centers for Disease Control and Prevention estimated
52,000 deaths, 275,000 hospitalizations, and 1,365,000 emergency department
visits resulting from TBI each year (Faul et al. 2010b). It is also estimated that as
high as 42% of TBIs are not included in these statistics because 1.2-4.3 million
survivors of mild TBI annually do not seek medical attention (Setnik and Bazarian
2007) and likely self-medicate.
Headache is among the most frequently reported symptoms following
diffuse brain injury in both adolescents (Butler 2013) and adults (Keidel and
Diener 1997; Nicholson and Martelli 2004; Lew et al. 2006; Theeler et al. 2013).
Clinical recommendations for treating headache after mild TBI suggest
analgesics

(e.g.

acetaminophen)

and

warn

against

non-steroidal

anti-

inflammatory drugs (NSAIDs) (e.g. aspirin and ibuprofen), because of risk for
intracranial bleeding (Maiese 2008). Despite the large proportion of mild TBI
survivors not seeking medical attention (Setnik and Bazarian 2007) who likely
self-medicate for post-traumatic headache, the role of over-the counter pain relief
medicines in the course of brain injury is not completely understood.
The mechanical forces of TBI initiate a cascade of secondary injury
processes, including inflammation, which continue for days to weeks following
injury (Werner and Engelhard 2007). In conflicting studies, cerebral inflammation
has been shown to contribute to either beneficial or deleterious effects after
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traumatic insult (for review, see (Morganti-Kossmann et al. 2002)). TBI triggers a
cascade of inflammation-mediating cytokines (Morganti-Kossmann et al. 2001;
Frugier et al. 2010; Semple et al. 2010; Ziebell and Morganti-Kossmann 2010),
which can elicit a range of responses including cell differentiation, immune
activation, and cell death (Allan and Rothwell 2001). For the present study, mFPI
experimental model in the mouse induces multifocal neuropathology with
translational application to mild diffuse TBI, or concussion. Principally in the first
day after mFPI in mice, we have reported significantly increased levels of proinflammatory cytokine IL-1β in the cortex (Rowe et al. 2013c) along with acute
neurological impairments manifested within one hour of injury (Rowe et al.
2013a). In diffuse TBI, the effects of clinically relevant acute pharmacological
inhibition of inflammation on functional outcome are not yet understood.
Secondary injury processes initiated by traumatic brain injury, including
inflammation, are tractable therapeutic targets. Inflammation in the wake of TBI
is, in part, mediated by the conversion of membrane-released arachidonic acid
into pro-inflammatory prostaglandins by cyclooxygenase-2 (COX-2) (Dash et al.
2000). NSAIDs are widely available over-the-counter drugs used to treat acute
pain and inflammation, with mechanisms of action to block COX-1 and/or COX-2,
thereby slowing the production of prostaglandins (Vane 1971). Acetaminophen,
on the other hand, is presented as an analgesic with actions on cannabinoid
receptors (Ottani et al. 2006; Dani et al. 2007), without inflammatory properties.
Previous studies suggest anti-inflammatory drugs improve outcome following
brain injury as early as 72 hours post-injury (Gopez et al. 2005; Ng et al. 2012;
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Thau-Zuchman et al. 2012; Chio et al. 2013; Gatson et al. 2013). Treatment with
the highly specific COX-2 inhibitor DFU [5,5-dimethyl-3(3-fluorophenyl)-4(4methylsulfonyl)phenyl-2(5H)-furanone], administered daily for three days following
lateral cortical impact in rats attenuated injury-induced prostaglandin production
in the brain and improved functional recovery measured by the Morris water
maze and neuroscore at 72 hours post-injury (Gopez et al. 2005). Carprofen, a
COX-2 inhibitor, administered daily for seven days following closed head injury
(CHI) in mice, also improved functional recovery (Thau-Zuchman et al. 2012).
Recovery of function measured by the NSS, however, was not present until 72
hours post-injury (Thau-Zuchman et al. 2012). Treatment with anti-inflammatory
minocycline for fourteen days following CHI in mice resulted in improved NSS
scores starting at 72 hours post-injury, with improvements lasting through day 7
(Ng et al. 2012). These studies suggest that inhibiting inflammation after mild to
severe TBI can improve functional recovery; however, there is evidence to
suggest that treatment with ibuprofen over an extended timeframe may worsen
cognitive outcome. Rats which were continuously treated with ibuprofen for four
months following lateral fluid percussion injury performed significantly worse in
the Morris Water Maze than non-treated brain-injured rats (Browne et al. 2006b).
Taken together, previous reports indicate that repeated doses of OTC
analgesics, depending on the timeframe, may be beneficial or detrimental to
recovery from TBI. The acute nature of neurological impairments induced by the
mFPI model necessitates acute behavioral analysis to assess the effects of
pharmacological intervention (Rowe et al. 2013a). The current study delivers
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ibuprofen and acetaminophen to determine if a single treatment with common
over-the-counter (OTC) analgesics after diffuse TBI promotes recovery or
worsens behavioral outcome.
Several pro-inflammatory cytokines, including IL-1β, also have been
characterized as sleep regulatory substances (SRSs) (Krueger and Majde 1995;
Krueger et al. 2007). Cytokines with dual roles as SRSs can modulate sleepwake behavior by acting on sleep circuits of the brain (Krueger et al. 2001a;
Krueger et al. 2007). Exogenous IL-1β increases non-REM sleep in rodent
models and humans (Tobler et al. 1984; Dinarello 1991; Opp et al. 1991).
Inhibiting endogenous IL-1 through the administration of IL-1 antagonists or IL-1
soluble receptors has been shown to inhibit sleep (Opp and Krueger 1994;
Takahashi et al. 1996; Fang et al. 1998). In mFPI in the mouse, increased IL-1β
occurred concomitantly with a period of increased post-traumatic sleep (Rowe et
al. 2013c). A recent study demonstrated that a single dose of ibuprofen
administered two hours after TBI significantly lowered IL-1β levels in the brain 24
hours after closed head injury (Keshavarzi et al. 2012). Together, these studies
highlight the dynamic relationship between sleep and inflammation in the context
of TBI. To this end, inflammation may contribute to acute post-traumatic sleep
(Rowe et al. 2013c).
The current study investigates the effects of acetaminophen and
ibuprofen—two common analgesic drugs with different anti-inflammatory
mechanisms—on neurological function, acute sleep profiles, and cortical cytokine
levels after diffuse TBI in the mouse. We hypothesize acute pharmacological
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inhibition of injury-induced inflammation will lead to a decrease in inflammatory
cytokines and acute post-traumatic sleep, possibly altering functional outcome.
Materials and Methods
Animals
Male C57BL/6 mice (Harlan Laboratories, Inc., Indianapolis, IN) were used
for all experiments (n=57). Mice were housed in a 12 h light/12h dark cycle at a
constant temperature (23°C ± 2° C) with food and water available ad libitum
according to the Association for Assessment and Accreditation of Laboratory
Animal Care International. Mice were acclimated to their environment following
shipment for at least three days prior to any experiments. After surgery, mice
were evaluated daily for post-operative care by a physical examination and
documentation of each animal’s condition. Animal care was approved by the
Institutional Animal Care and Use Committees at St. Joseph’s Hospital and
Medical Center (Phoenix, AZ).
Housing
All mice used in this study were singly housed. Mice were housed in
standard individually ventilated cages or housed in the non-invasive sleepmonitoring cage system (Signal Solutions, Lexington, KY).
Midline Fluid Percussion Injury (mFPI)
Mice (20-24g) were subjected to midline fluid percussion injury (mFPI)
consistent with methods previously described (Lifshitz 2008). Group sizes are
indicated in the results section and figure legends for individual studies. Mice
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were anesthetized using 5% isoflurane in 100% oxygen for five minutes and the
head of the mouse was placed in a stereotaxic frame with continuously delivered
isoflurane at 2.5% via nosecone. While anesthetized, body temperature was
maintained using a Deltaphase® isothermal heating pad (Braintree Scientific Inc.,
Braintree, MA). A midline incision was made exposing bregma and lambda, and
fascia was removed from the surface of the skull. A trephine (3 mm outer
diameter) was used for the craniotomy, centered on the sagittal suture between
bregma and lambda without disruption of the dura. An injury cap prepared from
the female portion of a Luer-Loc needle hub was fixed over the craniotomy using
cyanoacrylate gel and methyl-methacrylate (Hygenic Corp., Akron, OH). The
incision was sutured at the anterior and posterior edges and topical Lidocaine
ointment was applied. The injury cap was closed using a Luer-Loc cap and mice
were placed in a heated recovery cage and monitored until ambulatory before
being returned to their sleep cage.
For injury induction 24 hours post-surgery, mice were re-anesthetized with
5% isoflurane delivered for five minutes. The cap was removed from the injuryhub assembly and the dura was visually inspected through the hub to make sure
it was intact with no debris. The hub was then filled with normal saline and
attached to a tube connected to the male end of the fluid percussion device
(Custom Design and Fabrication, Virginia Commonwealth University, Richmond,
VA). An injury of moderate severity (1.4 atm) was administered by releasing the
pendulum onto the fluid-filled cylinder. Sham-injured mice underwent the same
procedure except the pendulum was not released. Mice were monitored for the
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presence of a forearm fencing response and righting reflex times were recorded
for the injured mice as indicators of injury severity (Hosseini and Lifshitz 2009).
The righting reflex time is the total time from the initial impact until the mouse
spontaneously rights itself from a supine position. The fencing response is a tonic
posturing characterized by extension and flexion of opposite arms that has been
validated as an overt indicator of injury severity (Hosseini and Lifshitz 2009). The
injury hub was removed and the brain was inspected for uniform herniation and
integrity of the dura. The dura was intact in all mice, none were excluded as
technical failures. The incision was cleaned using saline and closed using
sutures. Moderate brain-injured mice had righting reflex recovery times greater
than six minutes and a positive fencing response. Sham injured mice recovered a
righting reflex within 20 seconds. After spontaneously righting, mice were placed
in a heated recovery cage and monitored until ambulatory (approximately 5 to 15
minutes) before being returned to their cage. Adequate measures were taken to
minimize pain or discomfort.
Pharmacological Intervention
All mice received either vehicle or drug treatment immediately following
induction of injury or sham. Drugs were administered intraperitoneally in 100µl of
sterile vehicle solution of normal saline and 15% (v/v) ethanol. Drug-treated mice
received either ibuprofen (60 mg/kg; Sigma-Aldrich, St. Louis, MO) or
acetaminophen (40 mg/kg; Sigma-Aldrich, St. Louis, MO). These doses were
chosen with respect to clinically relevant doses. Dose translations from human to
mice were based on body surface area (Reagan-Shaw et al. 2008) and were
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maintained within the maximum daily dose recommended by the United States
Federal Drug Administration (www.fda.gov). Both drugs were compared to the
same vehicle-treated control group treated with normal saline and 15% (v/v)
ethanol.
Behavioral Testing
Rotarod. Sensorimotor function was assessed using the Economex Rotarod
system from Columbus Instruments (Columbus, OH). Mice were pre-trained for
three consecutive days. The first two days were acclimation (60 sec at 4 RPM for
3 trials) and on day three baseline scores were collected using the test day
procedures (see below). For the test at 24 hours post-injury, mice were placed on
the rod with a starting speed of 4 RPM, and rod rotation speed was continuously
increased over 5 minutes up to a max speed of 28 RPM, as previously published
(Bachstetter et al. 2013). The trial ended when the mouse fell from the rod or 5
minutes elapsed. Two trials were performed at each time point. Data are
presented (average of two trials) as latency to fall in seconds and total distance
traveled in centimeters. Improvement in performance is presented as the
difference in each mouse’s baseline score and test day score, where positive
numbers indicate improvement in the task.
Neurological Severity Score (NSS). Post-traumatic neurological impairments
were assessed at 24 hours post-injury using an 8-point NSS paradigm adapted
from those previously used in experimental models of TBI (Chen et al. 1996;
Semple et al. 2010; Pleasant et al. 2011; Ziebell et al. 2011). One point was
given for failure on an individual task, and no points were given if a mouse
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completed a task successfully. Mice were observed for hind limb flexion, startle
reflex, and seeking behavior (presence of these behaviors was considered
successful task completion). Mice traversed in sequence, 3, 2, and 1 centimeter
beams. The beams were elevated and mice were given 1 minute to travel 30
centimeters on the beams. The task was scored as a success if the mouse
traveled

30

centimeters

with

normal

forelimb

and

hindlimb

position

(forelimb/hindlimb did not hang from the beam). Mice were also required to
balance on a 0.5 centimeter beam and a 0.5 centimeter round rod for 3 seconds
in a stationary position with front paws between hind paws. Non-parametric data
are presented as a composite score ranging from 0 to 8 representing
performance on all tasks combined. High final NSS scores were indicative of task
failure and interpreted as neurological impairment.
Sleep Recordings
The non-invasive sleep cage system (Signal Solutions, Lexington, KY)
consisted of 16 separate units that could simultaneously monitor sleep and wake
states, as previously published (Rowe et al. 2013c). Each cage unit housed a
single mouse inside 18 x 18 centimeter walled compartments with attached food
and water compartments (Donohue et al. 2008). The cages had open bottoms
resting on Polyvinylidine Difluoride (PVDF) sensors serving as the cage floor
(Donohue et al. 2008). The non-invasive high-throughput PVDF sensors were
coupled to an input differential amplifier and pressure signals were generated
and classified by an algorithm (see below) as motions consistent with either wake
activity or the inactivity and regular breathing movements associated with sleep
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(Donohue et al. 2008). Briefly, sleep was characterized primarily by periodic (3
Hz) and regular amplitude signals recorded from the PVDF sensors, typical of
respiration from a still mouse. In contrast, signals characteristic of wake were
both the absence of characteristic sleep signals and higher amplitude, irregular
spiking associated with volitional movements. The piezoelectric signals in two
second epochs were classified by a linear discriminant classifier algorithm based
on frequency and amplitude to assign a binary label of “sleep” or “wake”
(Donohue et al. 2008). Mice sleep in a polycyclic manner (more than 40 sleep
episodes per hour) (McShane et al. 2010). For experimental studies, mouse
sleep was quantified as the minutes spent sleeping per hour, presented as a
percentage for each hour. Sleep activity data were binned over specified time
periods (e.g. 1 hour) to calculate the average of percent sleep.
Tissue preparation and cytokine quantification
At 24 hours post-injury mice were given an overdose of sodium
pentobarbital and transcardially perfused with ice cold phosphate buffered saline
(PBS). Mice were decapitated and the brains were dissected on ice. Cortical
biopsies (2mm diameter x 2mm thickness) were taken and snap frozen in
methanol cooled over dry ice then stored at -80°C. The protein levels of a panel
of inflammation-related cytokines were measured by Quansys Biosciences
Mouse Cytokine IR Q-Plex assay (Quansys Biosciences, Logan, UT), according
to manufacturer protocol. Cortical biopsies were bead-homogenized using a
Precellys 24 in 200 µl of ice-cold Tris-buffered lysis solution supplemented with
protease inhibitor cocktail (Complete Protease Inhibitor Cocktail Mini Tablet,
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Roche Diagnostics, Mannheim, Germany). The cortical homogenate was
centrifuged at 3000 RCF for 20 minutes at 4°C in a microcentrifuge. The resulting
supernatant (25µl) was loaded per well of the Q-Plex plate, and cytokine levels
were determined by Q-Plex assay. Cytokine levels in the cortex were normalized
to the total amount of protein in the sample, as determined by BCA Protein Assay
(Thermo Scientific, Rockford, IL).
Statistical Analysis
Data are shown as mean ± SEM and analyzed using statistical software
(GraphPad-Prism 6). For analysis of behavior and sleep, uninjured shams from
all drug treatment groups were combined and used as a single control (see
results). Differences in rotarod performance following TBI were determined by
one-way analysis of variance (ANOVA) followed by Sidak’s multiple comparisons
test. Non-parametric NSS data were analyzed by Kruskal-Wallis ANOVA,
followed by Dunn’s comparison post-hoc test (see results). Percent sleep was
analyzed using a repeated measure two-way ANOVA followed by Sidak’s
multiple

comparisons

test

when

appropriate.

Differences

in

cytokine

concentrations were analyzed by two-way ANOVA. Statistical significance was
assigned when p<0.05.
Results
It was not anticipated that drug treatment would change functional
outcome or mean percent sleep in the uninjured sham mice. Statistical analysis
confirmed no significant change in rotatrod performance, neurological severity
score, or mean percent sleep between any sham treatment groups. Vehicle-
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treated, ibuprofen-treated, and acetaminophen-treated shams were combined
into a single control. As anticipated, anti-inflammatory treatment altered cytokine
levels in sham treatment groups; cytokine data were analyzed without combining
shams.
Diffuse TBI reduced motor performance on the rotarod task regardless of
pharmacological intervention.
To assess motor function we used the rotarod task as previously
published (Bachstetter et al. 2013). Across groups, there was a significant effect
on latency to stay on the rotarod (F(3, 53)=3.688, p=0.0174; Figure 5.1A; sham
n=27, vehicle-treated injury n=10, ibuprofen-treated injury n=12, acetaminophentreated injury n=8). Rotarod latency was significantly reduced in vehicle-treated
and ibuprofen-treated brain-injured mice compared to sham mice at 24 hours
post-injury (Figure 5.1A). There was no significant latency reduction in
acetaminophen-treated brain-injured mice compared to shams (Figure 5.1A).
Further analysis of rotarod performance confirmed the latency data with distance
traveled, showing similar significant effects on distance traveled (F(3, 53)=3.909,
p=0.0135; Figure 5.1B). Distance traveled was significantly reduced in both
vehicle and ibuprofen-treated brain-injured mice compared to uninjured sham.
There was no difference in distance traveled by acetaminophen-treated braininjured mice compared to shams. To compensate for trial-based learning,
improvement in motor performance was analyzed. Latencies (Figure 5.1C) and
distances (Figure 5.1D) of each mouse at 24 hours post-injury were compared to
their individual baseline scores at training. Brain-injured mice treated with vehicle
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and ibuprofen showed significantly less improvement in latency to stay on the rod
compared to the improvement of uninjured shams (F(3, 53)=4.553, p=0.0065;
Figure 5.1C). Acetaminophen-treated brain-injured mice did not show a
difference in improvement compared to uninjured shams (Figure 5.1C). All braininjured mice, regardless of treatment, showed significantly less improvement in
distance traveled compared to shams (F(3, 53)=6.017, p=0.0013; Figure 5.1D).
Overall, diffuse brain injury reduced motor performance measured on the rotarod
task, without an effect of post-injury pharmacological treatment.
Diffuse

TBI

resulted

in

neurological

impairments

regardless

of

pharmacological intervention.
All brain-injured mice showed significant neurological impairments
measured by the neurological severity score (NSS) compared to uninjured
shams, regardless of pharmacological intervention (KW(4, 57)=27.37, p<0.001;
Figure 5.2; sham n=27, vehicle- treated injury n=10, ibuprofen-treated injury
n=12, acetaminophen-treated injury n=8). At 24 hours post-injury all brain-injured
groups had significantly higher NSS scores compared to uninjured shams. There
was no significant effect of post-injury pharmacological treatment.
Pharmacological intervention led to increased post-traumatic sleep
following diffuse brain injury.
Sleep-wake activity was recorded non-invasively immediately following
diffuse brain injury or sham injury. Initial analysis focused on the first six hours,
as post-traumatic sleep was increased in our previous reports (Rowe, 2013).
Acetaminophen- treated brain-injured mice had significant increases in sleep
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during the first six hours post-injury compared to uninjured shams (mean ±SEM;
F(1, 29)=11.98, p=0.0017; Figure 5.3C). There was no significant increase in the
vehicle-treated (F(1, 30)=0.8886, p=0.3534; Figure 5.3A) or ibuprofen-treated
(F(1, 30)=1.853, p=0.1835; Figure 5.3B) groups compared to shams. Further
analysis of sleep focused on the dark cycle following injury (the time the
nocturnal mice should be awake), to evaluate the mouse equivalent of ‘human
daytime sleepiness’. There was a significant increase in ibuprofen-treated braininjured mice (F(1, 30)=4.540, p=0.0410; Figure 5.4B) compared to uninjured
shams. While the acetaminophen-treated brain-injured group showed an
increase in mean percent sleep compared to sham, this increase failed to reach
statistical significance (F(1, 29)=3.939, p=0.0567; Figure 5.4C). Unexpectedly,
the vehicle-treated mice had a significant decrease in sleep (F(1, 30)=4.455,
p=0.0432; Figure 5.4A) following brain injury compared to uninjured shams.
Overall, brain-injured mice had increased mean percent sleep during the dark
cycle following drug treatment.
Inflammation-related interleukin cytokines were not increased in the cortex
at 24 hours post-injury.
Upon brain dissection, no differences in hemorrhage or gross pathology
were noted between groups. A panel of inflammatory related interleukin
cytokines was evaluated at 24 hours post-injury in whole cortex. There was no
statistically significant increase or decrease in protein concentrations of cytokines
in the cortex of brain-injured mice compared to uninjured shams (Table 5.1).
Cytokines evaluated included: IL-1α (F(1, 23)=1.996, p=0.1711), IL-1β (F(1,
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23)=0.01040,

p=0.9197),

IL-2

(F(1,

23)=0.2045,

p=0.6554),

IL-6

(F(1,

23)=0.3326, p=0.5697), IL-10 (F(1, 23)=0.3581, p=0.5554) and IL-12 (F(1,
23)=0.1672, p=0.6864). IFNγ, IL-4, and TNFα levels were also evaluated, but
concentrations were undetectable.
Discussion
In

the

intervention

diffuse

with

brain-injured

over-the-counter

mouse,
analgesics

immediate
did

not

pharmacological
adversely

affect

sensorimotor or neurological outcome. A single, clinically relevant dose of
ibuprofen or acetaminophen was hypothesized to reduce early inflammation and
prevent (or delay) the increased injury-induced sleep necessary for recovery,
thereby leading to a worsened functional outcome. In the current study, we show
immediate treatment with ibuprofen or acetaminophen increased sleep within the
first 24 hours of injury, without impacting TBI-induced functional deficits
measured by the rotarod and neurological severity score (NSS). We also show
drug treatment did not alter expression of cortical cytokines at 24 hour postinjury.
Given the majority of human TBI encompasses mild to moderate diffuse
brain injury for which self-medication may be the primary treatment, the current
study sought to investigate the clinical situation in which a survivor of mild TBI
self-treats with a single dose of an OTC analgesic medicine. The most frequent
symptom after TBI is post-traumatic headache TBI (Theeler et al. 2013), making
ibuprofen and acetaminophen principal choices for self-medication. Administering
one dose of over-the-counter (OTC) analgesics immediately following brain injury
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mimics the at-home treated population of concussed patients and may accelerate
the understanding of the relationship between brain injury and OTC
pharmacological intervention. Administering ibuprofen, an NSAID and COX
inhibitor, in opposition to administering acetaminophen, an analgesic with weak
anti-inflammatory properties, allowed for the investigation of inflammation
inhibition on brain injury-induced deficits.
While clinical and experimental data suggest the chronic over-production
of pro-inflammatory cytokines contributes to the progression of pathology in TBI
(Schmidt et al. 2005; Lloyd et al. 2008; Cao et al. 2012), the role of immediate
inflammation is less clear. Inflammation is critical to the repair process and health
of the organism, however, inflammation that is excessive or prolonged can
exacerbate damage after the primary injury (Bachstetter et al. 2013). Previous
reports have shown that multiple doses of analgesics can alter not only functional
outcome but also cellular mechanisms following experimental TBI, see review
(Rowe et al. 2013b). In this study, a single dose of ibuprofen or acetaminophen
given at the time of injury did not attenuate or exacerbate injury-induced
sensorimotor or neurological deficits measured 24 hours post-injury. Previous
studies suggest anti-inflammatory drugs can improve outcome following brain
injury as early as 72 hours post-injury (Gopez et al. 2005; Ng et al. 2012; ThauZuchman et al. 2012; Chio et al. 2013; Gatson et al. 2013). Treatment with the
highly

specific

COX-2

inhibitor

DFU

[5,5-dimethyl-3(3-fluorophenyl)-4(4-

methylsulfonyl)phenyl-2(5H)-furanone], following lateral cortical impact in rats
attenuated injury-induced prostaglandin production in the brain and improved
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functional recovery measured by the Morris water maze and neuroscore at 72
hours post-injury (Gopez et al. 2005). Carprofen, a COX-2 inhibitor, administered
following closed head injury (CHI) in mice, also improved functional recovery
(Thau-Zuchman et al. 2012). Recovery of function measured by the NSS,
however, was not present until 72 hours post-injury (Thau-Zuchman et al. 2012).
Treatment with anti-inflammatory minocycline following CHI in mice resulted in
improved NSS scores starting at 72 hours post-injury, with improvements lasting
through day 7 (Ng et al. 2012). These studies suggest that inhibiting inflammation
can improve functional recovery. While the administration of analgesics has been
primarily shown to positively influence functional outcome, these studies have
incorporated multiple dosing strategies either before or after TBI. While the
results are experimentally valid, they do not address the situation faced by a
mildly concussed individual not seeking medical attention. In this scenario, an
individual would likely self-treat prominent symptoms, including headache, with
OTC analgesics immediately post-injury. Experimentally, it would be expected
that a single dose of OTC analgesics would have less profound effects upon
outcome than a more aggressive dosing strategy.
In the current study, we found that a single dose of OTC analgesics did
not attenuate or exacerbate TBI induced functional deficits. Sensorimotor deficits
measured by the Rotarod task were present in brain-injured groups compared to
uninjured shams regardless of drug treatment at the time of injury. Similarly,
brain-injured groups had neurological deficits measured by a modified NSS
compared to uninjured shams regardless of drug treatment. Multiple studies have
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shown analgesics to provide neuroprotection from TBI when administered
continually, such that a single clinically relevant dose of OTC analgesics does not
affect the pathophysiological and molecular cascades induced by diffuse brain
injury. In this way, any initial inhibition of inflammation provided by a single
analgesic dose may not prevent the development of neurological deficits by 24
hours post-injury. It is also possible that the route of drug administration used in
this study reduced the bioavailability of the compounds. Alternate administration
routes could increase the bioavailability of the drugs, and should be considered
for future studies, recognizing the reduced clinical applicability. Overall, this study
shows one dose of OTC analgesics given immediately following injury does not
alter functional outcome. Given that the OTC analgesics administered in the
current study did not worsen behavioral outcome, they may be safe for the
clinical treatment of post-traumatic symptoms. It is of note, though, that some
anti-inflammatory drugs, including ibuprofen, are not indicated for clinical use
after TBI due to their anti-coagulant effects increasing the possibility of
intracranial bleeding (Maiese 2008).
Using our injury model, we have previously demonstrated an injuryinduced increase in inflammatory cytokines which have dual roles as SRSs
(Bachstetter et al. 2013; Rowe et al. 2013c) as well as an increase in posttraumatic sleep starting at the time of injury and persisting for the first six hours
(Rowe et al. 2013c). In the current study, we show a significant increase in posttraumatic sleep over the first six hours following injury in the acetaminophentreated brain-injured mice compared to the uninjured shams. This increase in
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sleep is not present in the ibuprofen-treated brain-injured mice. Ibuprofen, an
NSAID, is used to treat both pain and inflammation (Wyatt et al. 2012). Ibuprofen
may inhibit the injury-induced immediate increase of SRS cytokines, thereby
preventing the increase of post-traumatic sleep in the first six hours post-injury.
Acetaminophen, an analgesic with weak anti-inflammatory properties, would not
inhibit the upregulation of pro-inflammatory cytokines as seen by an increase in
inflammation-induced

sleep.

However,

the

study

design

precluded

measurements of cytokines prior to 24 hours. Unexpectedly, the vehicle-treated
brain-injured mice did not have an injury-induced increase in post-traumatic sleep
as previously published by our lab (Rowe et al. 2013c). It is possible that the
vehicle itself or stress from the injections contributed to this unexpected sleep
profile. It is possible that using low doses of ethanol as the vehicle contributed to
decreases in mean percent sleep. Clinical studies indicate low doses of ethanol
have contributed to decreases in total sleep (Roehrs et al. 1999; Geoghegan et
al. 2012).
Further analysis of sleep profiles examined mean percent sleep during the
dark cycle following injury, a time when nocturnal mice are usually awake.
Disturbances during this period would be compared to excessive daytime
sleepiness in humans, which is a commonly reported clinically after TBI
(Castriotta et al. 2007; Verma et al. 2007; Baumann 2012). Data indicate that
vehicle-treated brain-injured mice slept significantly less than uninjured shams
during this time. In contrast, increases in mean percent sleep were observed in
both ibuprofen and acetaminophen-treated brain-injured mice compared to
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uninjured shams, although mean percent sleep in acetaminophen treated mice
failed to reach significance (p=0.0567). It is possible increasing the number of
mice in each group would reduce variability and this increase would reach
significance. This drug-injury interaction resulting in increased dark cycle sleep
models excessive daytime sleepiness not seen in vehicle-treated brain-injured
mice.
Inflammatory cytokines such as IL-1β, IL-6, and TNF-α promote sleep
(Krueger et al. 1995; Fang et al. 1998; Krueger et al. 2001a; Yasuda et al. 2005;
Krueger 2008). Our experimental model of concussion has shown elevated levels
of pro-inflammatory cytokines peaking between three and nine hours post-injury
(Bachstetter et al. 2013; Rowe et al. 2013c). In the current study, we measured a
panel of inflammation related interleukins at 24 hours post-injury to investigate
the presence or absence of inflammation at the time behavioral testing was
completed. As expected, based on previous temporal associations of injuryinduced cytokine levels in our injury model, there were no significant changes in
cytokine levels at 24 hours post-injury in any brain-injured group compared to
uninjured shams. Inflammation mediates behavioral, biochemical, and systemic
changes which collectively make up the acute phase response, characterized by
fever and changes in metabolism and sleep patterns (Gabay and Kushner 1999).
Our study measured cytokines identified as key regulators of the acute phase
response including IL-1β, IL-6, IL-8, and TNFα (Gabay and Kushner 1999). In
line with previous findings (Keshavarzi et al. 2012), there were no significant
changes in these cytokines at 24 hours post-injury, suggesting that acute
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inflammation following experimental diffuse brain injury has resolved, which may
or may not emerge at later time points.
Overall, immediate pharmacological intervention following brain injury did
not adversely impact functional outcome as indicated by performance on the
rotarod and NSS task. Further investigation is needed to determine if multiple
doses of over-the-counter analgesics attenuate injury-induced deficits. It is
possible that chronic treatment may impact the course of recovery following TBI.
Ibuprofen administered chronically over a four month period to rats subjected to
FPI led to a decline in cognitive function, as measured by the Morris water maze
(Browne et al. 2006b). Future studies should extend the functional evaluation
beyond 24 hours post-injury. It is possible that the single dose given in this study
may have improved or worsened functional outcome at later post-injury time
points.
Conclusion
In

the

diffuse

brain-injured

mouse,

immediate

pharmacological

intervention altered sleep profiles, but did not attenuate or exacerbate TBIinduced functional deficits. This study is significantly limited by the single 24 hour
time point. Our previous studies document a rapid increase in inflammatory
cytokines; however, this study only investigates inflammation-related interleukin
cytokine levels at 24 hours after injury. At this time point it is not possible to
conclude whether the anti-inflammatory drug affected the expression of
inflammatory cytokines or not. Future studies should measure cytokine levels at
earlier time points (i.e. 6, 9 hours) in order to identify the relationship between the

123

tested anti-inflammatory drugs and their effect on inflammatory cytokine.
Furthermore, inflammation at later time points, including the 24 hour point, should
be evaluated using the presence of microglia activation. This would be a more a
useful measure of inflammation that extends beyond the initial cytokine surge.
While the one-time drug dose offers clinical relevance, it is possible chronic
administration would have improved functional outcome. There may also be a
more optimal one time dosing of the OTC drugs that was overlooked in the
preparation of this study. Previous work in a mouse model of TBI suggests a
lower one-time dose following TBI was beneficial to neurological outcome (Hall
1985). We conclude that inhibition of immediate injury-induced inflammation may
prevent an early increase in post-traumatic sleep but does not adversely affect
functional outcome. Further investigation is needed to examine the role of
immediate post-traumatic sleep on recovery following TBI.
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Chapter Five: Figures

Figure 5.1 No adverse effects of pharmacological intervention on injuryinduced motor deficits on the rotarod task.
(A) Injury significantly impaired motor performance as indicated by reduced
latency to stay on the rotarod (mean ±SEM; F(3, 53)=3.688, p=0.0174), with
significant differences between vehicle-treated and ibuprofen-treated braininjured mice compared to uninjured shams at 24 hours post-injury. There was no
significant

difference

between

acetaminophen-treated

brain-injured

mice

compared to uninjured shams. (B) Reduced distance traveled on the rotarod
also indicated a significant injury-induced impairment in motor function (mean
±SEM; F(3, 53)=3.909, p=0.0135). There was a significant difference between
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vehicle-treated and ibuprofen-treated brain-injured mice compared to uninjured
shams at 24 hours post-injury. There was no difference in distance traveled by
acetaminophen-treated brain-injured mice compared to uninjured shams. (C)
Injury significantly impaired improvement in latency to stay on the rotarod from
baseline (mean ±SEM; F(3, 53)=4.553, p=0.0065) indicated by a difference
between vehicle-treated and ibuprofen-treated brain-injured mice compared to
uninjured shams at 24 hours post-injury. (D) Injury also significantly impaired
improvement in distance traveled (mean ±SEM; F(3, 53)=6.017, p=0.0013)
between vehicle-treated, ibuprofen-treated, and acetaminophen-treated braininjured mice compared to uninjured shams at 24 hours post-injury. (sham n=27,
vehicle-treated injury n=10, ibuprofen-treated injury n=12, acetaminophen-treated
injury n=8; *, p<0.05; **, p<0.01).
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Figure 5.2 No adverse effects of pharmacological intervention on injuryinduced neurological impairments.
Significant neurological impairments were detected between groups, as
measured by modified neurological severity score (mean ±SEM; KW(4,
57)=27.37, p<0.001). Dunn’s multiple comparisons test indicated vehicle-treated,
ibuprofen-treated,

and

acetaminophen-treated

brain-injured

mice

showed

significantly higher NSS scores compared to uninjured shams 24 hours postinjury. There were no significant changes in function between any brain-injured
groups regardless of treatment. (sham n=27, vehicle-treated injury n=10,
ibuprofen-treated injury n=12, acetaminophen-treated injury n=8; *, p<0.05; ***,
p<0.001).
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Figure 5.3 Acetaminophen-treated mice slept significantly more than
uninjured mice in the six hours immediately following diffuse TBI.
In the first six hours post-injury no significant change was detected in percent
sleep between (A) vehicle-treated brain-injured (mean ±SEM; F(1, 30)=0.8886,
p=0.3534) as well as (B) ibuprofen-treated brain-injured mice (mean ±SEM; F(1,
30)=1.853, p=0.1835) compared to uninjured sham groups. (C) Acetaminophentreated brain-injured mice slept significantly more compared to uninjured shams
(mean ±SEM; F(1, 29)=11.98, p=0.0017). Additionally, the difference in percent
sleep between injured and uninjured mice was detected at 14:00. (sham n=26,
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vehicle-treated injury n=6, ibuprofen-treated injury n=6, acetaminophen-treated
injury n=5; **, p<0.01)
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Figure 5.4 Vehicle-treated mice slept significantly less and ibuprofentreated mice slept significantly more during the first dark-cycle post-injury
compared to uninjured shams.
(A) In the first dark cycle post-injury there was a significant decrease in percent
sleep between vehicle-treated brain-injured mice (mean ±SEM; F(1, 30)=4.455,
p=0.0432) compared to uninjured shams. (B) Ibuprofen-treated brain-injured
mice had a significant increase in mean percent sleep (mean ±SEM; F(1,
30)=4.540, p=0.0410) compared to uninjured shams. (C) Increases in mean
percent sleep of acetaminophen-treated brain-injured mice compared to
uninjured shams failed to reach significance (mean ±SEM; F(1, 29)=3.939,
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p=0.0567). (sham n=26, vehicle-treated injury n=6, ibuprofen-treated injury n=6,
acetaminophen-treated injury n=5).
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Table 5.1 Inflammation-related interleukin cytokines were not altered in the
cortex at 24 hours post-injury.
Data are presented as concentration levels (mean ±SEM; pg/ml/mg). No injuryinduced increases or decreases in cortical interleukins were detected 24 hours
post injury. There were also no changes in cortical cytokine levels among vehicle
and drug treated groups. IL-1α (F(1, 23)=1.996, p=0.1711), IL-1β (F(1,
23)=0.01040,

p=0.9197),

IL-2

(F(1,

23)=0.2045,

p=0.6554),

IL-6

(F(1,

23)=0.3326, p=0.5697), IL-10 (F(1, 23)=0.3581, p=0.5554), IL-12 (F(1,
23)=0.1672, p=0.6864). IFNγ, IL-4, and TNFα levels were evaluated, but found to
be undetectable. (vehicle sham n=5, acetaminophen sham n=5, ibuprofen sham
n=5, vehicle- treated injury n=4, ibuprofen-treated injury n=5, acetaminophentreated injury n=5).
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Chapter Six: Overall Conclusions
The physiological consequences of TBI often develop into neurological
impairments which impact outcome and quality of life of survivors. While acute
sleep disturbances are among one of the most commonly reported clinical
neurological impairments following TBI, there is a lack of investigations into the
duration, manipulation, and implications of this post-traumatic sleep. The work of
this thesis was designed as a first step in identifying the role of post-traumatic
sleep in recovery from diffuse brain injury. Data from these studies outline an
animal model of diffuse TBI which produces an increase in acute sleep coinciding
with the frequently reported symptom of excessive sleepiness post-concussion in
man. Further, the studies included in this thesis manipulated aspects of posttraumatic sleep in order to identify its contribution to the post-injury recovery
process. Combined, this creates a framework of preliminary studies on which
future work in the field of sleep and TBI can be built.
In summary, we have shown diffuse brain injury promotes acute posttraumatic sleep in the mouse, and the secondary injury related inflammatory
processes coincide with this increase. Second, we determined the injury-induced
increase in sleep was present during the first week post-injury, but was not
maintained thereafter using this injury model. Third, disrupting acute posttraumatic sleep following diffuse TBI did not worsen functional outcome. Fourth,
immediate pharmacological intervention altered sleep profiles, but did not
attenuate or exacerbate TBI-induced functional deficits.

134

Cumulatively, our studies indicate experimental diffuse brain injury
increased sleep immediately following injury, extending through the first week
post-injury. Data showed the injury-induced increase in sleep is not a primary
event. Analyzing post-traumatic sleep in five minute intervals showed the
increase in mean percent sleep over the first-hour post-injury was time
dependent. This supports the conclusion that injury-induced cellular cascades
contribute to the overall sleep increase. If the primary impact solely contributed to
post-traumatic sleep, then an immediate increase in post-traumatic sleep to a
maximum level would have been observed.
Secondary injury responses were temporally associated with the observed
increase in post-traumatic sleep. IL-1β increased immediately following injury and
returned to baseline by twelve hours. We also show activation of microglia at six
hours post-injury. Activated microglia can contribute to the production of IL-1β,
which in turn acts locally to affect neuronal assemblies, altering their functional
status and acting on sleep regulatory circuits (Krueger et al. 2007). Our injury
model induces an activation of microglia for the first seven days post-injury
(Ziebell et al. 2012). It is likely that activated microglia act as effectors of circuit
disruption, extended beyond local circuits to sleep regulatory circuits contributing
to an increase in sleep (Krueger and Majde 1995; Krueger et al. 2001a), which
did not persist in our model.
Evidence of microglia activation during the first week post-injury (Ziebell et
al. 2012) supports the hypothesis that microglia signaling processes may
contribute to the overall increase in sleep during the first week post-injury which
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is not extended into weeks two through five. Chapter Three concludes our injury
model does not successfully produce chronic sleep disturbances documented by
clinical studies. This discordance of mouse data with clinical data suggests this
mouse model does not adequately reflect the human condition. It is possible that
using an animal that does not exhibit polycyclic sleep pattern, may be more
appropriate to model the chronic sleep disturbance reported by TBI survivors. It
is also possible a more severe experimental brain injury may be necessary to
induce secondary damage that develops into sleep disturbances at chronic time
points.
The present body of work also demonstrated disruption of immediate posttraumatic sleep does not worsen injury-induced motor or cognitive deficits. It is
likely that both rodents and humans can recover from transient sleep disruption
after brain injury without significant functional consequence. It is possible that
sleep disruption prior to injury of longer durations could contribute to a worsened
outcome. The results from this dissertation suggest an increase in immediate
post-traumatic sleep, extending throughout the first week post-injury, is a natural
response to brain injury. In light of the progress toward understanding the role of
post-traumatic sleep in the recovery from TBI, further experimentation is required
to determine the cellular benefit or detriment, if any, of acute post-traumatic
sleep. While sleep may aid in recovery, from Chapter Four we conclude
disruption of immediate post-traumatic sleep does not worsen outcome in our
injury model.
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Limitations of Chapter Four include the lack of injury induced cognitive
deficits. Following diffuse brain injury mice did not show a cognitive deficit within
the 7 day time point. It is possible that our injury model induces circuit disruption
and that the reorganization of these circuits at later time points (i.e. 28 days)
post-injury may produce measurable injury-induced cognitive deficits. Following
diffuse brain injury with our model, minimal damage to the hippocampus
contributes to a lack in cognitive deficit at 7 days. The limited cognitive deficit
prevents us from determining if disrupting post-traumatic sleep worsened
cognitive outcome. Cognitive behavior needs to be evaluated at multiple time
points extending chronically to investigate the possibility of late onset cognitive
deficits with our injury model. Establishing a timeline of the development of
cognitive deficits following diffuse brain injury would facilitate future studies in
order to draw a conclusion whether sleep disruption after TBI worsens cognitive
outcome following diffuse injury.
The studies presented in this dissertation also showed a single dose of
analgesics administered following TBI is not sufficient to prevent the
development of injury-induced deficits, nor did the administration exacerbate
impairments. Following a mild concussion, OTC drugs are taken to relieve
headache associated with the injury. These studies focus on the individuals
relieving immediate pain as opposed to survivors self-medicating to treat chronic
headaches associated with TBI. Drug administration did contribute to changes in
sleep

profiles,

with

acetaminophen-treated

brain-injured

mice

sleeping

significantly more than uninjured shams over the first six hours post-injury.
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Ibuprofen-treated and vehicle treated brain-injured mice did not have an increase
in sleep compared to uninjured shams over the first six hours post-injury. These
differences in acute post-traumatic sleep did not contribute to differences in
functional outcome measures which are in line with our findings from Chapter
Four which suggest disrupting sleep in the first six hours does not contribute to a
worsened outcome. We conclude from Chapter Five that a single dose of OTC
analgesics does not affect outcome following experimental diffuse brain injury.
In the Chapter Five the study is significantly limited by the single 24 hour
time point. Chronic dosing may have a different effect on outcome. The 24 hour
time point is also limiting in the conclusions that can be draw from the
inflammatory cytokines. Our previous studies document a rapid increase in
inflammatory cytokines; however, this study only investigates inflammationrelated interleukin cytokine levels at 24 hours after injury. At this time point it is
not possible to conclude whether the anti-inflammatory drug affected the
expression of inflammatory cytokines or not. Future studies should measure
cytokine levels at earlier time points (i.e. 6, 9 hours) in order to identify the
relationship between the tested anti-inflammatory drugs and their effect on
inflammatory cytokine. Furthermore, inflammation at later time points, including
the 24 hour point, should be evaluated using the presence of microglia activation.
This would be a more a useful measure of inflammation that extends beyond the
initial cytokine surge.
In summary, the studies presented in this dissertation have made
progress towards our goal of informing clinical recommendations for the at-home
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treated population of mildly concussed individuals. With a lack of research on TBI
and acute sleep, it is imperative that an animal model is established in which
scientific questions can be investigated. The studies from this thesis outline an
injury model that accurately models the acute increase in sleep reported by TBI
survivors. The studies of this thesis will help future investigators test hypotheses
in the field of sleep and TBI.
Future Experiments
Throughout these experiments some questions have been answered, at
the same time we are now positioned with several exciting opportunities for
future investigations. Potential future experiments were recommended in the
discussion sections for each chapter; however, there are additional studies that
could further the advancement of post-traumatic sleep following diffuse brain
injury. Foremost would be the extension of time points to investigate if immediate
sleep disruption has implications in functional outcome at chronic time points;
here our behavioral assessments were restricted to the first week post-injury.
Likewise, extending the behavioral evaluation in drug studies, as well as
increasing the dosing regimen, would more fully evaluate pharmacological
interventions following diffuse TBI.
Our current studies indicate interleukin-1, a pro-inflammatory cytokine with
dual roles as a sleep regulatory substance, is part of the acute inflammatory
response following TBI. In order to further investigate the mechanistic link
between inflammation and post-traumatic sleep, future experiments should focus
on the interleukin-1 receptor antagonist (IL-1ra), which modulates inflammatory
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cascades by blocking the binding of IL-1 to its signaling receptor. If the
transgenic overexpression of IL-1ra prevents the injury-induced increase in IL-1
(an SRS), then it is hypothesized mice would sleep less after TBI in comparison
to wild type brain-injured mice.
Additionally, adding a second injury in the six hour window where acute
post-traumatic sleep occurs would allow further evaluation of vulnerable time
periods post-injury. Studies could investigate repetitive head injury that occurs
within the first six hours compared to a second insult after the first six hours.
Clinical studies would allow for further analysis of post-traumatic sleep following
TBI. Monitoring the sleep of patients admitted to the emergency room with a TBI,
through electroencephalography recordings, may provide clinical insight for
injury-induced sleep. Sleep measurements could be evaluated and conclusions
could be drawn based on injury severity and sleep duration as well as on the
overall impact sleep has on injury prognosis. If sleep is differentially promoted
(duration, stage etc.) between injury severities, evaluation of immediate posttraumatic sleep could become a potential diagnostic tool for TBI.
Controversy exists in both the medical and lay communities regarding
opposing suggestions for individuals not being allowed to sleep or frequently
awoken following injury. The controversy is fueled by an absence of peerreviewed biomedical literature on the topic of acute post-traumatic sleep. The
data from this thesis begin to dispel the controversies regarding sleep and brain
injury. Collectively, these data suggest sleep is part of the natural recovery
process and self-medicating with acetaminophen or ibuprofen and falling asleep
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immediately following a mild concussion is an appropriate at-home treatment
plan.
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Appendix

Anesthetics and analgesics in experimental traumatic brain injury:
Selection based on experimental objectives

Summary
The use of animal modeling in traumatic brain injury (TBI) research is
justified by the lack of sufficiently comprehensive in vitro and computer modeling
that incorporates all components of the neurovascular unit. Valid animal
modeling of TBI requires accurate replication of both the mechanical forces and
secondary

injury

conditions

observed

in

human

patients.

Regulatory

requirements for animal modeling emphasize the administration of appropriate
anesthetics and analgesics unless withholding these drugs is scientifically
justified. The objective of this review is to present scientific justification for
standardizing the use of anesthetics and analgesics, within a study, when
modeling TBI in order to preserve study validity. Evidence for the interference of
anesthetics and analgesics in the natural course of brain injury calls for
consistent consideration of pain management regimens when conducting TBI
research. Anesthetics administered at the time of or shortly after induction of
brain injury can alter cognitive, motor, and histological outcomes following TBI. A
consistent anesthesia protocol based on experimental objectives within each
individual study is imperative when conducting TBI studies to control for the
confounding effects of anesthesia on outcome parameters. Experimental studies
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that replicate the clinical condition are essential to gain further understanding and
evaluate possible treatments for TBI. However, with animal models of TBI it is
essential that investigators assure a uniform drug delivery protocol that
minimizes confounding variables, while minimizing pain and suffering.
Introduction
TBI is a serious health epidemic contributing to death and permanent
disability. The United States Centers for Disease Control and Prevention
estimate that 1.7 million individuals sustain a TBI annually in the United States
alone (Faul et al. 2010a). There is currently no pharmacological treatment for
individuals who suffer the lifelong neurological morbidities associated with TBI
and efforts to lower the high incidence are primarily preventive. Animal models
have been designed to parallel pathological processes in humans to reproduce a
consistent injury (O'Connor et al. 2003). The validity of TBI animal models to the
clinical condition makes them powerful tools in evaluating post-traumatic
morbidity and testing rational therapeutic interventions after brain injury. When
using research animals, the consideration of animal welfare is vital and pain and
distress should be minimized. However, the introduction of anesthetics during
experimental TBI and the use of analgesics for post-traumatic pain management
can interfere with post-injury processes and functional outcomes. In this
overview, we discuss how the use of anesthetic and analgesic compounds can
affect evaluation of functional and histopathological outcomes following
experimental TBI and how their selection or exclusion should be established
based on experimental objectives.
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Need for TBI models
Federal research regulations require that all reasonable alternatives which
could adequately answer the proposed question be explored before considering
a study that incorporates animals. The complex neurovascular responses after
TBI require investigations that involve the immune, circulatory, and central
nervous systems of live animals. The long term consequences of diffuse TBI
include a host of emotional, cognitive, and sensory deficits that can degrade
quality of life. Specific aspects of brain injury, such as cell death, have been
successfully modeled with in vitro neural injury (Morrison et al. 1998; Geddes et
al. 2003). However, in vitro models cannot be sustained over chronic time points
to evaluate injury progression, and lack the complex interactions among systems
that characterize TBI neuropathy. Additionally, current computer models cannot
reproduce the complicated pathophysiology of TBI. A wide range of wellaccepted animal models are available for neurotrauma investigation (see table
A.1), and the use of whole animal models is justified for TBI research and
deemed appropriate for conduct of pre-clinical studies (Chen et al. 2008).
Therefore, neurotrauma research necessitates live animal models of human TBI,
which must be employed within the existing animal welfare regulatory
environment.
Experimental Animal Models of TBI
Traumatic brain injury is a complex process characterized by two
pathological phases: cellular injury resulting from a primary mechanical impact
and the ensuing secondary injury mediated by pathological processes (Werner
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and Engelhard 2007).

A range of experimental models of TBI are used in

research differing in primary injury mechanisms. Biomechanical mechanisms of
TBI can be classified as either focal or diffuse injury (see table A.1). Each model
can be used to answer specific scientific questions. The majority of experimental
brain injury research relates to mild and moderate human injuries, which do not
involve coma. For this reason, rodents are rarely kept in drug induced sedation or
coma after injury. All brain injury models have been carried out beyond six
months to evaluate histopathology, behavior, and biochemistry.
Animal Welfare in TBI Research
The privilege of conducting research on living animals demands high
levels of responsibility. The use of animals in research must be justified from an
ethical cost-benefit perspective where animal pain, morbidity, and mortality must
be outweighed or balanced by the potential benefits of the experimental findings
to human or animal health, advancement of knowledge, or good of society.
Investigators are obligated to minimize the amount of pain and distress in
animals utilized for research. Withholding anesthetics, analgesics, or tranquilizers
can only be allowed if it is scientifically justified by investigators and subsequently
approved by an institutional animal care and use committee (IACUC). Studies in
which animals are subjected to painful or stressful conditions without the use of
anesthetics, analgesics, or tranquilizers are classified by the USDA and Animal
Welfare Act as Category E. Category E studies must show that less painful or
stressful alternatives are not available, or that less painful/stressful endpoints
cannot be reasonably substituted. Since human TBI occurs in the absence of
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anesthetics and analgesics, which can confound outcomes (see below),
scientifically well-justified, complete, and accurate studies using in vivo models of
TBI can be classified as Category E procedures in which drugs can be withheld.
Pain and TBI
By its nature, TBI is associated with acute and chronic pain both in animal
models and man (Walker 2004; Nampiaparampil 2008). The initial trauma elicits
somatic pain, and secondary injury mechanisms contribute to visceral and
neuropathic pain (Walker 2004). Measures to reduce nociception and distress
should be implemented before, during, and following surgical procedures (deep,
general anesthesia) and scientific objectives must be balanced against the use of
anesthetics and analgesics in experimental animal models of TBI to protect
animal welfare and prevent unnecessary suffering. Administration of anesthetics
and analgesics can both positively and negatively influence post-injury processes
and elicit functional changes in animal models of TBI, thus, these drugs should
be selected based on experimental objectives. Consistent control of anesthetics
and analgesics (drug choice and dose) throughout a study will help alleviate
confounding factors that may influence post-injury outcome measures. The
standardization of pain management within a study will also permit cross study
comparisons.

Pharmacological

pain

management

immediately

following

experimental TBI in animal models can influence post-injury outcomes (see
below), therefore selection should be based on IACUC approved experimental
objectives. This review is intended to aggregate examples of research-based
instances of anesthetic and analgesic interference on TBI outcome measures.
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Anesthetics in TBI Research
Anesthetics induce a variety of reversible effects depending on the
concentrations at which they are delivered (Campagna et al. 2003). At lower
concentrations inhaled anesthetics induce euphoria, amnesia, and hyperreflexia,
but as concentrations increase anesthetics can lead to deep sedation and
diminished somatic and autonomic responses to stimuli (Campagna et al. 2003).
Inhaled anesthetics target both the spinal cord and the brain with differing
mechanisms of action. The amnesic actions of inhaled anesthetics are mediated
within the brain, depressing blood flow and glucose metabolism, with greater
levels of depression in regions such as the thalamus and midbrain reticular
formation (Campagna et al. 2003). Most inhaled anesthetics alter receptormediated synaptic signaling and consequently synaptic transmission (Franks
2008). Absence of movement in response to painful stimuli can be mediated by
anesthetic action on the spinal cord, whereas general anesthesia results from
supraspinal sites of action (Eger 1984; Campagna et al. 2003; Antognini et al.
2005). Local anesthetics are used for topical pain management by reversibly
inhibiting sodium currents and thereby nerve impulses (Strichartz 1976).
When using animal models to replicate clinical TBI, anesthetics are
routinely administered during surgical procedures to minimize pain and
discomfort as well as provide immobilization. However, anesthetics used during
the induction of experimental TBI can interfere with histopathological and
functional outcomes. Commonly used anesthetics can provide varying degrees of
neuroprotection, suggesting that the choice of anesthetics used in TBI models

147

can greatly alter post-injury outcome (Statler et al. 2006b). For example,
isoflurane, an inhaled anesthetic commonly used in veterinary medicine, has
been shown to facilitate functional outcome in comparison to other anesthetics
following the controlled cortical impact (CCI) model of TBI in rats, possibly
through modulation of excitotoxicity or an increase of cerebral blood flow (Statler
et al. 2000). Rats anesthetized with isoflurane and subjected to CCI performed
better on motor tests (beam balance, beam walking) as well as cognitive tests
(Morris Water Maze) compared to rats anesthetized intravenously with fentanyl
(Statler et al. 2000). Isoflurane also attenuated hippocampal damage, specifically
to the CA1 region when compared to fentanyl (Statler et al. 2000). A follow-up
comprehensive study evaluated cognitive outcome following CCI in the rat with
the administration of several anesthetics and provided support that different
anesthetics in experimental TBI critically influence outcome (Statler et al. 2006a).
In all cases, animals treated with anesthetics differed from untreated animals.
Isoflurane-treated rats exhibited the most improved latency times in the Morris
Water Maze compared to rats injected with fentanyl or diazepam, which trended
toward longer latencies to locate the platform (Statler et al. 2006a). The analysis
of cresyl violet staining to investigate neuronal survival in brain tissue following
CCI provided evidence that different anesthetics protect against cell death to
varying

extents.

Again,

isoflurane

treatment

demonstrated

the

most

neuroprotection against hippocampal cell death, whereas rats treated with
ketamine following CCI demonstrated the least protection against hippocampal
cell death (Statler et al. 2006a). Isoflurane modulates excitotoxicity by reducing
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the release of glutamate (Patel et al. 1995) as well as blocking NMDA receptors
(Bickler et al. 1994) which may mechanistically contribute to neuroprotection
(Statler et al. 2006a).
Although preconditioning with isoflurane has produced beneficial effects in
animal models of TBI (Statler et al. 2000; Statler et al. 2003; Statler et al. 2006a;
Statler et al. 2006b), Hertle et al. recently published data suggesting deep
sedation using isoflurane negatively influences neurological outcome in a rat
model of TBI (Hertle et al. 2012). Rats preconditioned with isoflurane and
subjected to CCI demonstrated increased cortical damage assessed by apoptotic
cell markers and a worsened neurological outcome measured by a standardized
inclined plane test (Hertle et al. 2012). Investigating the cerebral protective
effects of anesthetics used in combination with hypothermia following diffuse TBI
has shown that propofol may be a better treatment for head injury than isoflurane
(Kahveci et al. 2001). Propofol, a general injectable anesthetic similar to the
inhalant isoflurane (both of which

modulate GABA receptors (Kahveci et al.

2001; Krasowski et al. 2001)), used in combination with moderate hypothermia in
rats subjected to diffuse impact-acceleration TBI significantly lowered intracranial
pressure (ICP) and significantly raised cerebral perfusion pressure (CPP)
compared to isoflurane combined with hypothermia (Kahveci et al. 2001).
Investigation of ICP and CPP after diffuse impact-acceleration brain injury in rats
has shown that sevoflurane, a general inhalational anesthetic, raised ICP and
caused a more pronounced decrease in CPP than observed with isoflurane
treated animals (Goren et al. 2001). The authors proposed that different
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cerebrovasodilatatory effects of each anesthetic can account for the effects in
ICP (Goren et al. 2001). Similarly, administration of anesthetics themselves can
affect physiological conditions which influence outcome. Anesthetic delivery can
affect normal ventilation and carbon dioxide levels which consequently alter ICP,
CPP, and cerebral blood flow (CBF) (Reinert et al. 2003; Asgari et al. 2011;
Haubrich et al. 2011).
TBI initiates a cascade of secondary injury processes that define the
disease. Studies including but not limited to the ones above have shown that
administration of anesthetics shortly after experimental TBI can act on these
secondary injury mechanisms to mitigate or possibly exacerbate damage. The
administration of propofol in conjunction with the closed head injury model in rats
alters the synthesis of nitric oxide, ultimately reducing lipid peroxidation (Ozturk
et al. 2008). Yurdakoc et al. has shown similarly that, isoflurane given after
closed head trauma may protect against lipid peroxidation (Yurdakoc et al. 2008).
Altering lipid peroxidation, a secondary injury mechanism characteristic of TBI,
provides evidence that specific anesthetics may have neuroprotective effects on
head injuries through pathophysiological pathways and may change the natural
course of brain injury in animal models.
Anesthetic compounds which act as antagonists at the N-methyl-Daspartate (NMDA) receptor may also exhibit neuroprotective properties
(McIntosh et al. 1990; Jevtovic-Todorovic et al. 1998; Kawaguchi et al. 2005) that
improve outcome from TBI (Smith et al. 1993). Rats subjected to fluid percussion
injury and administered ketamine, an injectable non-competitive NMDA receptor
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antagonist, showed preserved memory function (Smith et al. 1993). However,
intraperitoneal injections of ketamine given to rats before CCI did not prevent TBI
induced intracerebral cytokine production and had minimal effect on the early
local inflammatory response (Ward et al. 2011). Thus, ketamine can alter the
course of brain injury through mechanisms other than inhibition of inflammation.
The administration of anesthetics during TBI modeling interferes with
neurological outcome. Anesthetics can be neuroprotective, making them
beneficial treatments for TBI, however, contradicting studies conclude that
anesthetic administration may worsen outcome. For this reason, the use of
anesthetics in TBI modeling should be standardized within studies to provide
consistent timing and dosage. Compounds should be selected based on specific
experimental objectives for each study in accordance with local and federal
regulations. It is suggested that anesthetics be carefully controlled in studies
exploring the natural course of brain injury to preserve validity.
Analgesics in TBI Research
Ethical standards have been developed and enforced to protect the wellbeing of animals used for biomedical research. This includes proper pain
management following surgical procedures. However, post-surgical analgesics
have been shown to be neuroprotective and may confound the evaluation of
post-injury outcome measures (McIntosh et al. 1994; Raghupathi and McIntosh
1998). Conversely, chronic administration of analgesics following TBI has led to
worsened outcomes (Browne et al. 2006a). Comprehensive dosing paradigms of
common analgesic drugs have not been determined in all experimental TBI
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models. It is also not well known the degree of interference from drugs, whether
subtle or substantial, on molecular, functional and behavioral outcomes. This
inconsistency supports the claim that analgesics must be carefully considered
and tested before being administered following TBI in order to maintain a valid
and reproducible animal model.
Non-steroidal

anti-inflammatory

drugs

(NSAIDs)

are

commonly

administered to mitigate inflammation and accompanying pain. During the
inflammatory process, cyclooxygenase (COX) enzymes facilitate the conversion
of arachidonic acid into inflammation-mediating prostaglandins (Choi et al. 2009;
Strauss 2010). NSAIDs act to reduce prostaglandin synthesis by inhibiting the
production of COX-1 and COX-2 (Simmons et al. 2004). NSAIDs and specific
COX-2 inhibitors are effective in suppressing inflammation, possibly by interfering
with secondary injury mechanisms.
As an apparent contradiction to the acute neuroprotective actions of some
NSAIDs, their chronic administration following TBI can negatively influence
functional outcome (Browne et al. 2006a). Ibuprofen administered chronically
over a 4 month period to rats subjected to fluid percussion injury led to a
worsening in cognitive function measured by the Morris Water Maze (Browne et
al. 2006a). These results show the complexity of analgesic administration postinjury and lend caution to the selection and duration of analgesics in animal
models of TBI.
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Carprofen, an NSAID, administered to mice after a closed head injury
(CHI) results in improvements in neurobehavioral function (Thau-Zuchman et al.
2012). Mice receiving carprofen following TBI exhibited a more rapid and
pronounced improvement of neurological deficits measured with the Neurological
Severity Score when compared to mice receiving vehicle treatment (ThauZuchman et al. 2012). In addition, rats receiving nimesulide, a COX-2 inhibitor,
after a diffuse TBI using the impact acceleration model showed improvement in
functional and motor deficits (Cernak et al. 2002). Treatment with nimesulide
improved mean escape latencies over the post-injury assessment period in
comparison to vehicle-treated controls using the Barnes circular maze to assess
spatial reference memory. Motor deficits, measured using the rotarod test, were
also attenuated after treatment with nimesulide following TBI (Cernak et al.
2002). Similarly, 5,5-dimethyl-3(3-fluorophenyl)-4(4-methylsulfonyl)phenyl-2(5H)furanone (DFU), a selective COX-2 inhibitor, has been shown to improve
neurological reflexes and memory when administered following cortical impact in
the rat, as compared to administration of a vehicle control (Gopez et al. 2005).
Thus, analgesics can interfere with the natural course of the injury toward an
improved recovery of function.
Endogenous and administered opioids attenuate responses to many
painful stimuli in both humans and animals. TBI causes increased release of
endogenous opiate receptor agonists which contribute to the trauma-induced
secondary injury cascade (Hall et al. 1987; McIntosh et al. 1987a; Zohar et al.
2006). For example, morphine administration immediately following TBI in the
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mouse confounds the evaluation of cognitive deficits as measured in the Morris
Water Maze task (Zohar et al. 2006), where mice treated with morphine
immediately post-injury were protected from long–term but not short term
cognitive deficits (Zohar et al. 2006). Morphine has also been shown to reduce
behavioral deficits when given to rats just prior to diffuse brain injury induced by
fluid percussion (Hayes et al. 1990; Hamm et al. 1993; Lyeth et al. 1993).
Morphine given in combination with scopolamine, a muscarinic receptor
antagonist, provided even greater protection on motor performance (Lyeth et al.
1993). These results suggest that administering opioids following TBI alters the
natural course of brain injury.
Further, the administration of analgesics following TBI not only alters
functional outcome, but also alters the pathophysiological course of the injury.
Brain-injured mice treated with carprofen had a significant decrease in lesion size
post-injury (Thau-Zuchman et al. 2012). Carprofen-treated mice showed
increased cell proliferation and gliogenesis in comparison to vehicle-treated
controls (Thau-Zuchman et al. 2012). The administration of other analgesics,
such as nimesulide, has been shown to alter cellular mechanisms following
experimental TBI (Cernak et al. 2002). Rats subjected to an impact accelerationinduced TBI exhibited a marked increase in COX-2 protein expression in the
hippocampus (Cernak et al. 2002). Based upon the hypothesis that COX-2
mediates the production of prostanoids (including prostaglandins), inhibiting
COX-2 expression with an analgesic should attenuate aspects of secondary
injury and neurological deficits following experimental TBI (Cernak et al. 2002).
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Administration of other analgesics following TBI in the rat attenuated the amount
and intensity of immunoreactive COX-2 in the cortex as compared to vehicletreated controls (Gopez et al. 2005). Rats administered analgesics after TBI have
also shown a decreased number of activated caspase-3-immunoreactive cells in
both the injured cortex and hippocampus (Gopez et al. 2005). Thus, the
administration of analgesics post-injury can prevent cell death and alter the
pathophysiology of experimental TBI. For these reasons, it is imperative to
design analgesic protocols for post-operative care that do not inhibit the
processes being evaluated following experimental TBI.
While analgesics and anesthetics have great potential to confound the
natural of course brain injury, justified pain management in experimental animals
remains of utmost concern. Investigators have the obligation to minimize animal
pain and distress in their research protocols. Perioperative pain management
should be based on experimental objectives in light of the potential confounds on
assessment outcomes.
Conclusions
Valid animal modeling of TBI requires accurate replication of both the
mechanical forces and secondary injury conditions experienced by human
patients. The interference of anesthetics and analgesics in the natural course of
brain injury calls for special consideration of pain management drugs when
conducting TBI research. Our analysis of these studies indicates that anesthetics
administered at the time of or shortly after the impact alter outcome following TBI.
To protect animal welfare anesthetics cannot be completely avoided, however, a
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consistent (drug and dose) intra-study anesthesia protocol is imperative when
conducting TBI studies. Similarly, studies indicate the administration of
analgesics to control perioperative pain may alter outcome following TBI. Due to
the variability among traumatic brain injury models and experimental outcome
measures, uniform recommendations for anesthesia and analgesia are not
practical. For this reason, recommendations for specific drug choice and dosing
were not included in this review. Investigators are urged to establish a standard
of animal care specific to individual experimental objectives based on pilot study
data.
Additional Considerations
Differences in outcome among physically similar individuals following
equivalent traumatic brain injuries can be particularly noticeable. Minimizing
confounds of analgesic and anesthetic drugs are only one step toward
conducting valid and reproducible animal modeling of TBI. Differences in weight,
sex, age at injury, and genetic background can influence recovery by altering
how individuals sustain the mechanical forces and endure the secondary injury
processes of brain injury.
The Appendix is published in the following review:
Rowe RK, Harrison JL, Thomas TC, Pauly JR, Adelson PD, and Lifshitz J. (2013). Using
anesthetics and analgesics in experimental traumatic brain injury.
This is a copy of an article published in the [Lab Animal] © [2013] [copyright Nature
publishing
group];
[Lab
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online
at:
http://www.labanimal.com/laban/index.html

Copyright © Rachel Kathleen Rowe 2013
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Appendix: Tables
Model

Fluid Percussion
Injury (FPI)

Description
Fluid pressure pulse delivers mechanical forces onto
exposed brain. Can be performed laterally or centrally.
Requires craniectomy.

Controlled
Cortical Impact
(CCI)

Computer controlled pneumatic piston drives into
cortex, creating a focal injury. Requires craniectomy.

Blast Injury

Compressed gas delivers pressure wave, resulting in
a diffuse injury. Minimal surgical preparation.

Impact
Acceleration
Injury

Weight is dropped onto head supported by foam pad.
Scalp incision may be required.

Weight Drop
Injury

Weight is dropped onto head supported by metal
base. Scalp incision may be required.

Penetrating
Injury

Projectile is driven into the brain causing a focal injury.
Requires craniectomy.

Refs
(McIntosh et
al. 1987b;
McIntosh et
al. 1989;
Thompson et
al. 2005;
Alder et al.
2011)
(Lighthall
1988; Dixon
et al. 1991;
Saatman et
al. 2006)
(Cheng et al.
2010; Reneer
et al. 2011;
Risling and
Davidsson
2012)
(Heath and
Vink 1995;
Schmidt et al.
2000; Pandey
et al. 2009)
(Feeney et al.
1981; Foda
and
Marmarou
1994;
Marmarou et
al. 1994;
Kilbourne et
al. 2009)
(Williams et
al. 2005;
Williams et al.
2006;
Plantman et
al. 2012)

Table A.1 Traumatic brain injury models.
Summary table of representative animal models of traumatic brain injury
including mechanism of injury and degree of surgical invasiveness.
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Drug

TBI
Model

Behavioral

Histological

Isoflurane

CCI

+

+

Physiological

Refs
(Statler et al.
2000; Statler et
al. 2006b)

+

(Bickler et al.
1994; Patel et
al. 1995; Statler
et al. 2006a)

Isoflurane

CCI

Isoflurane

CCI

Isoflurane

WD

+

(Yurdakoc et al.
2008)

Propofol

IA

+

(Kahveci et al.
2001)

Sevoflurane

IA

-

(Goren et al.
2001)

Propofol

WD

+

(Ozturk et al.
2005)

Ketamine

FPI

+

Ketamine

CCI

+

+

Carprofen

WD

+

+

Nimesulide

IA

+

+

(Cernak et al.
2002)

DFU

CCI

+

+

(Gopez et al.
2005)

Morphine

WD

+

(Zohar et al.
2003)

Morphine

FPI

+

(Lyeth et al.
1993)

Scopalamine

FPI

+

(Lyeth et al.
1993)

Ibuprofen

FPI

-

(Browne et al.
2006a)

-

(Hertle et al.
2012)

-

(Smith et al.
1993)
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-

(Ward et al.
2011)
(Thau-Zuchman
et al. 2012)

Table A.2 Anesthetic and Analgesic Effects
Summary table of anesthetic and analgesic effects on the natural course of
behavioral, histological, and physiological outcomes from experimental brain
injury. Experimental objectives assessed using (+) to indicate improvement or
positive outcome and (-) to indicate worsening or negative outcome.
CCI=Controlled Cortical Impact, WD=Weight Drop, IA=Impact Acceleration,
FPI=Fluid Percussion Injury.
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